rfhg_59240.1

Basic information about the TSS

---

TSS ID: rfhg_59240.1 Species: human Chr: chr4		Start: 76987605 End: 76987640 Strand: +
Source datasets	FANTOM5|DBTSS
Protocol	CAGE|TSS-seq
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000512333.1:148 GeneID: 55752 HGNC/MGI_ID: HGNC:25589 UniProt_ID: Nearer transcript ids and distances:

Gene_name: septin 11 Gene_symbol: SEPTIN11 Gene_synonyms: FLJ10849 Gene_source: HGNC:25589

TATA-Box annotation

---

Distance to TSS:	37870
Nearest PromoterID:	NM_018243
Entrez ID:	55752
Nearest Unigene:	Hs.128199
Nearest Refseq:	NM_018243
Nearest Ensembl:	ENSG00000138758
Gene Name:	septin 11
Gene Alias:	SEPT11
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.305556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SEPTIN11 p2@SEPTIN11 p3@SEPTIN11 p4@SEPTIN11 p5@SEPTIN11 p6@SEPTIN11 p7@SEPTIN11 p8@SEPTIN11 p9@SEPTIN11 p10@SEPTIN11
Sample		p1@SEPTIN11	p2@SEPTIN11	p3@SEPTIN11	p4@SEPTIN11	p5@SEPTIN11	p6@SEPTIN11	p7@SEPTIN11	p8@SEPTIN11	p9@SEPTIN11	p10@SEPTIN11
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	32.73	13.64	6.82	0.78	0.39	0.78	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	36.21	13.76	6.88	0.61	0.61	0.61	0.00	0.00	0.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	30.86	12.73	6.17	0.58	0.58	1.16	0.00	0.00	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	34.93	11.02	4.99	0.83	0.00	0.00	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	38.24	11.92	6.97	0.22	0.67	0.00	0.00	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.23	11.24	4.26	0.58	0.58	0.78	0.00	0.00	0.58	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	43.58	12.86	5.66	0.65	0.65	0.87	0.22	0.00	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	36.82	9.69	5.81	0.24	0.48	0.48	0.00	0.00	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	39.54	10.90	4.92	0.00	0.43	0.64	0.00	0.00	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	60.86	4.06	6.38	0.58	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	59.83	7.68	6.06	0.81	0.00	0.00	0.00	0.00	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	56.92	8.54	5.29	2.44	0.41	0.41	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.06	8.38	6.29	0.48	0.16	0.16	0.16	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.37	9.17	5.71	0.60	0.00	0.15	0.00	0.00	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.29	9.00	6.81	0.44	0.22	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.07	8.55	3.27	0.00	0.50	0.00	0.00	0.00	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.54	5.68	4.15	0.87	0.22	0.00	0.22	0.00	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.39	5.91	3.37	0.42	1.27	0.00	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.26	9.60	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.38	7.52	4.66	0.90	0.30	0.00	0.00	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.24	9.62	5.48	0.53	0.00	0.13	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11.91	10.18	6.04	0.35	0.17	0.35	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.25	9.95	4.91	0.26	0.13	0.13	0.00	0.00	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.92	10.92	5.34	0.24	0.24	0.00	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.96	9.29	2.84	0.52	0.26	0.00	0.00	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.66	7.91	5.38	0.00	0.00	0.32	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.38	7.14	2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.03	14.15	6.13	0.00	0.24	0.94	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.18	9.21	6.30	0.65	0.00	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.75	11.40	6.88	0.36	0.36	0.18	0.00	0.00	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.28	8.79	4.19	0.00	0.42	0.42	0.00	0.00	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.90	6.84	5.67	0.20	0.00	0.00	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.98	8.02	6.12	1.06	0.42	0.00	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.15	12.54	6.27	0.66	0.49	0.33	0.16	0.00	0.49	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.21	7.85	5.61	0.37	0.00	0.56	0.37	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.56	8.24	5.75	0.38	0.00	0.00	0.19	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.85	11.24	5.11	0.61	0.20	0.20	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.50	9.07	5.24	0.00	0.60	0.40	0.60	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.26	8.91	5.67	0.00	0.54	0.00	0.00	0.27	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.00	10.08	4.80	0.72	0.24	0.24	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.53	8.70	4.23	0.71	0.24	0.00	0.00	0.24	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	17.71	11.27	6.73	0.44	0.15	0.15	0.44	0.15	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.45	9.28	5.27	0.84	0.42	0.21	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	15.56	9.62	6.82	0.35	0.17	0.17	0.00	0.00	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	24.09	12.45	7.03	0.40	0.80	0.20	0.40	0.00	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.61	13.96	8.61	0.93	0.00	0.23	0.23	0.00	1.16	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.87	8.64	5.28	0.72	0.48	0.24	0.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.27	8.35	5.96	0.60	0.89	0.00	0.00	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.74	7.66	3.35	0.48	0.72	0.00	0.00	0.00	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.44	11.73	5.05	1.21	0.00	0.20	0.00	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	32.79	11.68	6.15	1.23	0.41	0.82	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.57	17.79	6.23	1.78	0.44	0.44	0.22	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	97.95	13.99	0.00	27.98	41.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	25.90	11.36	4.26	1.42	0.35	0.35	0.71	0.00	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.57	14.58	4.64	0.66	0.33	0.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	35.24	27.68	9.23	5.03	8.39	5.87	0.00	0.00	5.03	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	28.93	17.45	5.97	0.92	0.92	0.92	0.00	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.34	14.91	4.86	0.32	0.65	0.00	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.48	11.56	4.50	0.96	0.32	0.00	0.32	0.00	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	29.23	22.32	13.20	1.26	0.63	0.63	0.31	0.00	0.94	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	12.69	5.64	0.00	0.71	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	11.78	3.36	0.00	0.00	0.56	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.86	23.88	15.13	4.78	3.18	4.78	0.00	0.00	3.98	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	37.03	16.65	9.85	1.02	0.00	1.36	0.00	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	28.27	13.00	5.52	0.97	0.65	0.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	22.01	12.78	7.10	0.35	0.00	1.06	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	48.49	80.82	0.00	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	134.26	39.49	7.90	39.49	23.69	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	35.10	18.53	10.24	1.95	1.95	0.00	0.49	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.76	17.36	12.89	2.48	2.48	1.98	0.00	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	41.75	19.70	13.60	0.00	1.41	0.00	0.47	1.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	57.63	23.51	19.54	0.99	0.99	1.66	0.33	0.33	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.88	18.25	13.61	2.17	0.93	0.93	0.93	0.00	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	41.28	14.98	16.82	0.61	0.92	1.22	0.00	0.31	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	252.15	31.84	19.64	3.33	1.74	1.43	3.33	1.90	0.95	0.63
Adipocyte - breast, donor2	11327-117E4	194.76	24.22	17.65	3.37	5.61	8.18	2.89	0.80	1.28	0.80
Adipocyte - omental, donor1	11473-119C6	326.47	34.22	23.79	1.78	0.89	1.65	1.53	4.83	0.64	0.64
Adipocyte - omental, donor2	11474-119C7	189.86	32.89	17.19	1.49	2.24	5.23	0.00	0.00	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	234.44	28.47	22.10	1.34	1.67	3.35	1.00	2.68	0.33	2.68
Adipocyte - perirenal, donor1	11476-119C9	125.05	20.42	17.23	0.64	1.91	1.28	0.64	1.28	3.19	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	74.77	3.30	11.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	45.61	16.71	7.23	0.45	0.90	0.00	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	67.77	20.68	14.42	1.56	0.70	1.22	0.17	0.17	0.52	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	122.23	37.55	25.42	2.15	0.78	0.39	0.59	0.39	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	64.86	10.55	10.81	1.29	0.51	0.26	0.77	0.00	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	100.08	26.20	19.24	1.67	0.00	0.56	0.84	0.56	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	75.24	42.91	15.87	0.00	0.59	1.18	1.18	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	243.15	42.95	31.37	1.93	0.64	0.88	0.97	0.40	0.08	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	67.46	21.95	11.62	0.32	1.61	0.65	0.00	0.00	0.32	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	87.44	23.46	9.60	0.53	2.13	1.07	1.60	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	131.88	26.71	8.35	2.23	0.00	0.00	0.00	0.56	0.00	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	181.33	21.21	19.96	1.25	1.66	0.83	1.25	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	74.60	18.59	9.80	1.00	0.25	0.75	0.00	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	141.70	26.83	11.45	1.96	2.62	0.65	0.33	0.65	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	159.24	18.88	18.88	0.91	0.30	0.30	0.00	0.30	0.61	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	19.89	3.54	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	1.79	1.08	0.00	0.00	0.36	0.00	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	57.57	4.68	7.20	0.36	0.54	0.18	0.00	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	6.69	1.67	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	38.01	5.55	4.31	0.00	0.21	0.00	0.62	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	55.84	27.12	11.79	1.49	0.34	0.23	0.23	0.00	0.11	0.23
Anulus Pulposus Cell, donor2	11463-119B5	34.78	23.51	12.00	0.24	0.49	0.24	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	80.87	11.23	11.68	2.25	1.35	3.15	0.90	1.35	0.45	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	68.16	11.29	13.46	2.60	4.34	2.60	0.87	1.30	0.43	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	79.19	12.84	4.28	6.42	2.14	0.00	0.00	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	65.46	12.55	9.27	4.18	2.69	2.99	0.30	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	84.73	18.97	17.71	2.53	2.53	3.79	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	58.09	11.88	4.62	3.96	0.66	3.30	1.32	1.32	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	55.23	11.05	8.77	2.60	1.95	1.95	0.32	0.97	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	68.45	15.53	10.19	3.40	0.97	1.46	1.46	0.00	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	75.42	8.91	7.72	5.34	0.00	0.59	0.00	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	64.40	14.31	11.68	5.27	1.88	2.26	1.51	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	55.15	10.89	11.61	4.35	0.73	0.73	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	51.40	16.30	6.27	2.51	1.25	2.51	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	113.17	16.47	10.05	0.99	0.33	0.00	1.81	1.15	0.33	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	54.59	10.92	10.92	5.46	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	91.38	14.93	8.44	2.41	0.45	0.15	0.75	1.21	0.75	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	77.15	13.93	8.57	3.21	0.00	3.21	2.14	2.14	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	92.96	14.36	11.15	2.27	0.94	0.94	1.32	1.32	0.38	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	91.14	10.16	8.55	1.87	2.67	1.34	2.14	1.07	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	61.45	10.73	6.83	4.88	1.95	1.95	0.98	0.00	3.90	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	83.43	16.25	10.62	1.99	1.49	1.33	0.66	1.66	0.17	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	79.25	7.20	4.80	3.60	0.00	0.00	0.00	1.20	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	70.80	7.08	10.62	7.08	0.00	0.00	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	81.82	14.41	10.81	1.20	1.89	1.20	1.20	0.69	0.86	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	25.17	0.00	4.19	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	78.64	14.56	14.08	4.85	0.49	1.46	1.46	0.49	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	96.38	15.18	9.49	1.90	1.90	1.52	0.76	0.76	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	82.37	13.33	6.06	1.21	0.00	0.00	1.21	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	68.40	11.97	12.54	3.99	0.57	2.28	1.71	0.00	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	83.59	15.39	8.55	3.21	1.07	0.64	0.64	1.28	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	74.33	8.78	5.42	1.81	1.29	1.03	0.77	0.52	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	66.16	11.26	9.38	3.75	2.82	0.94	1.41	1.88	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	71.06	9.97	9.32	1.61	1.29	2.25	0.96	0.00	1.29	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	59.93	7.85	5.71	0.71	0.71	0.71	0.71	0.00	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	60.83	8.77	7.60	4.68	1.17	1.75	0.00	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	67.14	14.15	9.03	1.81	0.60	0.60	1.81	0.90	0.30	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	59.40	5.94	4.75	4.75	1.19	0.00	0.00	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	67.13	13.73	13.22	2.54	2.54	3.05	1.02	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	80.74	17.06	10.44	3.82	1.27	2.04	1.53	1.78	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	51.46	11.44	2.54	1.27	1.27	1.27	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	61.28	13.81	8.20	2.59	1.73	1.29	0.43	0.00	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	73.03	14.18	11.43	3.60	0.64	0.64	1.48	0.42	0.64	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	56.55	9.28	5.51	3.48	0.29	0.87	0.58	0.29	0.58	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	56.68	14.17	7.56	0.94	0.94	1.89	2.83	1.89	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	67.13	12.54	9.32	2.20	0.68	1.36	0.51	1.36	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	71.81	13.90	11.58	4.63	2.32	0.00	0.00	0.00	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	73.94	19.01	10.56	2.11	0.00	0.00	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	87.48	13.08	13.94	3.43	1.29	2.79	0.86	0.64	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	69.19	12.63	6.62	2.41	1.20	1.20	1.80	1.20	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	58.32	10.21	3.64	2.92	0.73	0.73	0.73	1.46	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	81.84	16.78	13.10	2.76	0.69	0.92	0.46	1.15	0.46	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	66.31	10.20	5.10	10.20	7.65	10.20	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	127.88	15.76	9.92	1.53	0.25	0.00	0.76	0.51	0.00	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	99.09	11.77	11.77	2.27	0.83	1.45	0.41	1.45	1.03	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	76.19	10.10	4.90	2.75	1.53	1.84	1.22	1.84	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	71.22	15.30	8.13	4.30	1.91	3.35	1.91	1.91	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	80.05	10.87	9.31	3.99	2.22	1.77	0.89	1.11	1.11	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	64.08	7.63	4.58	4.58	0.00	3.05	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	65.36	16.62	12.74	4.43	1.66	1.11	2.77	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	86.59	14.83	9.80	3.44	1.59	1.32	1.59	1.85	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	63.60	10.54	4.36	3.27	2.54	1.45	1.82	2.18	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	42.37	24.81	8.11	0.12	0.12	0.12	0.74	0.00	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	31.66	14.38	7.02	0.17	0.17	0.34	0.00	0.17	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	25.38	14.68	6.08	0.00	0.21	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	199.04	55.77	44.62	3.83	1.39	2.09	0.70	1.05	1.39	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	127.15	42.06	25.56	1.13	2.26	2.43	0.65	0.00	1.78	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	216.88	55.79	42.51	2.24	2.68	2.98	1.94	0.75	0.75	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	58.49	22.82	18.92	0.92	2.64	1.38	0.00	0.00	0.34	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	62.64	24.68	16.54	0.88	0.75	0.88	0.00	0.00	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	66.23	22.65	12.97	0.68	0.80	1.25	0.00	0.00	0.11	0.00
Basophils, donor1	12241-129G9	9.42	2.62	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	23.81	5.05	3.25	0.00	0.36	0.36	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	6.76	2.50	2.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	2.59	1.94	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	1.37	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.83	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.73	1.87	2.70	0.00	0.00	0.21	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.60	2.99	1.61	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	12.42	9.18	5.22	0.18	0.54	0.72	0.00	0.00	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	27.48	11.65	9.78	0.93	0.47	2.10	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	37.73	9.91	7.04	1.60	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	20.68	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.33	1.13	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	10.39	1.48	0.74	0.00	0.19	0.19	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	9.66	1.54	0.88	0.22	0.00	0.00	0.00	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	3.40	0.85	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	4.55	1.14	0.76	0.38	0.00	0.38	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.25	2.30	0.66	0.00	0.00	0.66	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	5.20	0.87	0.87	0.00	0.14	0.43	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	4.83	0.30	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	6.63	0.71	0.71	0.00	0.00	0.24	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.35	0.67	0.00	0.00	0.00	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.86	0.00	0.55	0.00	0.00	0.28	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.21	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.74	0.59	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.10	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.35	0.22	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4.21	0.00	0.23	0.23	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	0.53	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.61	0.15	0.00	0.00	0.15	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.99	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.25	1.04	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.01	0.46	0.23	0.00	0.46	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.66	0.23	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3.77	0.27	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.14	0.17	0.52	0.00	0.17	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.37	0.42	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.94	0.92	0.55	0.00	0.18	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.05	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.79	0.52	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.97	0.00	0.37	0.00	0.37	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.60	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	0.00	1.23	0.00	0.82	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.66	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	7.42	0.23	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	3.92	0.22	0.22	0.44	0.22	0.22	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	7.39	0.69	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	3.90	0.00	0.65	0.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	4.20	0.31	1.09	0.00	0.16	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	6.81	0.52	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	7.36	1.11	0.45	0.45	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	4.34	0.00	0.00	0.00	0.00	0.00	0.26	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	7.03	0.22	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	4.42	0.42	0.21	0.00	0.21	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	7.46	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	5.33	0.00	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	3.22	1.07	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.92	0.78	0.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	11.51	2.47	2.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	10.16	2.18	2.18	0.00	0.00	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	16.66	1.01	2.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	50.51	5.25	4.85	0.00	0.40	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	46.74	6.39	5.99	0.00	0.00	0.40	0.00	0.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	51.21	10.04	2.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	47.19	6.18	3.37	0.00	0.00	0.00	0.00	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.42	8.64	8.27	0.75	0.00	0.38	0.00	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	28.41	7.67	5.64	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	33.21	6.78	2.50	0.36	0.00	0.36	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	30.62	6.12	1.22	0.00	0.61	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	25.62	6.40	3.05	0.30	0.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	7.66	1.79	1.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	6.74	1.35	1.35	0.00	0.00	0.00	0.00	0.00	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	4.60	1.44	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	9.48	1.42	0.95	0.00	0.00	0.00	0.00	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.83	3.51	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	0.00	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7.95	5.06	1.73	0.14	0.00	0.29	0.00	0.00	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	3.56	1.86	0.68	0.17	0.17	0.00	0.00	0.00	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.16	3.87	1.45	0.48	0.00	0.00	0.00	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.10	3.14	2.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.18	2.80	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	24.64	6.60	1.76	0.00	0.00	0.88	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.91	10.12	4.22	0.00	0.42	0.42	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	9.14	7.48	2.29	0.00	0.62	0.42	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	12.36	4.68	4.01	0.33	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	6.53	2.18	1.36	0.00	0.00	0.27	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	7.50	1.61	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	7.17	0.00	1.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	7.42	3.52	1.85	0.00	0.00	0.37	0.00	0.00	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	6.50	3.03	0.43	0.22	0.00	0.00	0.00	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	6.09	2.10	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.18	2.02	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	11.70	6.50	1.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.53	11.33	3.92	0.44	0.00	0.87	0.00	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	29.20	10.89	6.93	0.00	0.49	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	40.62	9.23	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	11.17	0.00	0.00	0.00	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	18.83	6.37	5.82	0.00	0.55	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	28.96	13.01	8.34	0.25	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	27.72	16.94	6.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	25.07	12.18	2.51	0.00	0.00	0.36	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	34.62	15.23	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	59.59	7.53	4.91	0.65	0.00	0.00	0.00	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	39.80	6.38	6.01	0.75	0.38	0.38	0.00	0.00	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	45.95	5.55	6.06	0.00	0.76	0.76	0.00	0.00	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.26	10.32	5.96	0.92	0.92	0.92	0.00	0.00	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	32.59	10.06	5.27	0.24	0.48	0.72	0.00	0.00	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.00	5.47	4.38	0.55	0.82	1.09	0.00	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.41	10.51	5.40	0.60	0.90	1.50	0.00	0.00	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.08	6.24	5.28	1.44	0.72	0.72	0.00	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.52	10.23	7.96	0.68	0.23	0.23	0.00	0.00	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	38.46	10.00	5.87	0.65	1.30	0.65	0.00	0.00	0.65	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	39.48	10.26	4.74	0.79	0.00	0.53	0.00	0.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	45.50	10.32	5.86	0.00	0.70	0.00	0.00	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	41.66	8.75	2.72	0.91	1.21	0.60	0.00	0.00	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	37.77	9.59	4.07	1.45	0.87	0.87	0.00	0.00	0.87	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	41.56	10.92	6.13	0.53	0.53	0.53	0.00	0.27	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	47.71	9.19	6.57	1.75	0.00	0.00	0.00	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	47.82	9.11	5.92	3.19	0.46	0.46	0.00	0.00	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	50.72	11.93	5.22	1.49	0.75	0.00	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	35.30	7.20	3.60	0.72	0.00	0.00	0.00	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	40.28	6.91	4.89	1.44	0.00	0.86	0.00	0.00	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.51	8.01	3.54	0.47	0.00	0.24	0.00	0.00	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	47.22	13.31	10.77	0.63	0.32	1.27	0.00	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	43.06	11.38	7.69	0.62	0.92	0.00	0.00	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	43.92	11.22	5.77	0.00	0.64	0.32	0.00	0.00	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	35.19	9.94	5.35	0.00	0.38	1.15	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	34.68	10.25	5.91	0.00	0.79	0.39	0.00	0.00	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.80	8.32	4.54	0.00	1.51	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.97	8.03	6.42	0.80	0.80	0.00	0.00	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	7.69	8.39	0.00	1.40	0.00	0.00	1.40	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	61.11	14.02	6.01	1.00	1.00	0.00	0.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	51.18	18.28	16.45	3.66	1.83	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	30.63	11.36	5.43	0.49	0.49	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	176.79	31.36	28.94	0.95	0.42	0.53	0.11	0.63	0.42	0.32
Chondrocyte - de diff, donor1	11261-116G1	108.16	33.28	17.68	0.35	0.69	1.39	0.69	0.69	0.00	1.04
Chondrocyte - de diff, donor2	11338-117F6	193.32	21.68	18.83	1.42	2.13	0.71	1.78	0.71	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	102.86	26.97	15.70	1.93	2.05	1.02	0.91	0.00	0.57	0.57
Chondrocyte - re diff, donor2	11339-117F7	93.11	38.50	19.70	0.00	1.79	0.90	1.79	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	37.61	10.92	5.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	70.35	68.97	19.16	2.30	0.92	0.80	0.23	0.00	0.23	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	50.88	50.66	15.39	1.50	1.71	2.57	0.21	0.21	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	55.49	46.02	16.64	1.33	1.24	1.86	0.00	0.09	0.27	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.20	16.69	7.89	0.18	0.37	0.28	0.00	0.00	0.09	0.09
Corneal Epithelial Cells, donor1	11526-119I5	2.63	1.98	0.88	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.62	1.79	1.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	83.37	13.04	9.25	1.16	0.17	0.83	0.00	0.00	0.50	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	87.68	10.09	13.25	0.95	0.32	0.32	0.00	0.00	0.00	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	13.80	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	46.33	10.26	6.59	1.40	0.43	0.76	0.00	0.00	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	70.72	15.37	10.25	0.00	0.34	0.00	0.00	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	113.60	30.03	17.63	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	48.88	18.39	10.16	0.48	0.00	0.48	0.00	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	76.55	10.51	8.34	1.00	1.17	0.17	0.00	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	44.59	4.11	6.45	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	74.38	10.18	8.20	0.28	0.28	0.85	0.00	0.00	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	73.92	9.04	7.86	0.00	0.39	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	38.10	5.82	4.36	0.29	0.29	0.00	0.00	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	59.76	8.94	8.94	0.71	0.71	1.65	0.00	0.00	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	39.80	7.54	4.91	0.35	0.35	0.00	0.00	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	53.20	15.96	8.42	0.89	0.22	0.44	0.00	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	68.46	21.30	11.26	0.30	0.00	0.30	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	103.18	25.37	17.76	0.28	0.28	0.00	0.00	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	35.36	5.65	6.83	0.30	0.00	0.30	0.00	0.00	0.00	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	37.49	6.25	5.73	0.00	0.00	0.00	0.00	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	25.66	8.37	6.10	0.00	0.57	0.71	0.00	0.00	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	77.62	12.80	10.40	1.20	0.00	1.20	0.00	0.00	0.40	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	39.31	6.29	5.24	0.52	0.52	0.52	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	108.59	18.39	13.54	1.99	0.87	0.99	0.00	0.00	0.12	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	78.87	14.77	13.25	0.87	0.65	0.65	0.00	0.00	0.65	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	104.30	14.66	13.68	0.49	0.61	0.37	0.00	0.00	0.12	0.73
Endothelial Cells - Vein, donor1	11267-116G7	48.91	5.69	3.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	57.98	6.29	7.68	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	50.40	9.11	9.42	0.79	0.16	0.47	0.00	0.00	0.31	0.16
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.13	1.47	0.49	0.00	0.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	440.07	40.64	31.61	8.62	2.46	3.28	2.46	18.88	2.05	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	54.42	14.67	6.68	1.09	0.55	0.33	0.66	2.85	1.20	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	80.50	18.85	9.75	2.82	1.08	0.76	0.33	3.36	2.60	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	116.55	22.68	15.16	2.30	1.46	1.21	1.21	8.13	0.73	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	174.00	39.44	23.06	0.68	0.55	0.14	9.42	19.11	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	170.44	33.12	17.93	2.95	3.38	3.38	1.90	10.23	1.05	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	92.49	22.92	17.65	0.79	0.26	0.53	0.79	8.17	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	78.73	20.93	10.96	1.66	0.33	2.66	0.66	2.99	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	86.64	16.78	10.89	0.00	1.36	0.91	0.45	1.36	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	70.49	12.13	8.34	1.52	0.00	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	47.16	6.47	8.83	1.10	0.63	0.47	0.79	1.58	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	115.79	32.43	22.73	0.61	0.91	0.00	0.30	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	88.33	24.49	17.26	0.89	0.51	1.02	0.38	0.25	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	55.03	15.77	11.07	0.30	0.76	0.91	0.00	0.15	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	72.09	40.87	13.40	0.67	0.54	0.40	0.13	0.13	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	81.11	62.56	16.83	2.16	2.59	1.29	0.00	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	38.08	17.58	1.46	1.46	4.39	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	41.52	8.99	4.84	0.00	0.23	0.00	0.23	0.00	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	43.08	30.53	9.33	0.51	1.19	0.34	0.34	0.17	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	58.70	20.66	11.27	0.94	0.70	1.64	0.00	0.00	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	44.34	8.02	6.13	0.00	0.47	0.47	0.47	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	83.89	18.37	13.66	0.85	1.09	1.93	0.24	0.00	1.09	0.36
Fibroblast - Dermal, donor4	11450-119A1	112.37	26.11	20.01	0.79	1.81	1.70	0.11	0.00	0.23	0.68
Fibroblast - Dermal, donor5	11454-119A5	150.20	32.80	30.35	0.87	1.57	1.92	0.52	0.17	0.52	0.87
Fibroblast - Dermal, donor6	11458-119A9	142.61	36.38	24.36	1.14	1.30	0.97	0.16	0.00	0.00	0.81
Fibroblast - Gingival, donor1	11237-116D4	160.75	36.44	26.24	0.83	1.04	1.04	1.67	0.00	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	546.79	56.85	41.92	4.19	3.67	2.88	3.67	2.62	0.52	1.83
Fibroblast - Gingival, donor2	11318-117D4	105.69	18.58	15.55	2.24	1.84	2.24	0.53	0.00	0.40	0.66
Fibroblast - Gingival, donor3	11394-118C8	164.66	41.96	30.17	0.48	0.87	0.68	1.16	0.00	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	225.44	50.91	39.48	0.00	0.00	1.04	2.08	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	170.21	25.73	22.03	1.41	3.35	3.00	1.23	0.35	0.70	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	324.11	39.29	27.44	1.87	2.18	2.65	1.40	0.31	0.31	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	238.27	38.00	22.72	2.03	2.30	1.76	2.30	0.41	0.41	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	178.20	16.94	6.70	0.35	0.00	0.00	1.41	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	381.99	53.23	27.35	3.66	1.32	1.17	2.05	1.75	0.58	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	390.65	53.31	25.23	3.68	2.86	3.00	3.68	1.36	0.41	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	447.11	38.94	34.99	2.41	2.74	1.86	3.40	1.43	0.44	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	311.09	66.18	38.45	1.76	2.64	1.32	2.79	0.44	0.44	1.32
Fibroblast - Lung, donor1	11270-116H1	47.58	6.80	12.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	149.22	31.34	25.37	0.00	0.00	4.48	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	95.18	17.30	16.25	0.63	1.27	0.42	0.00	0.00	0.84	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	29.99	10.83	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	43.36	9.79	8.39	0.00	0.00	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	1.96	0.56	0.00	0.00	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	90.13	11.37	12.59	0.00	0.00	0.00	0.81	0.41	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	39.94	3.99	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	71.48	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	149.36	24.05	20.95	1.75	1.55	1.55	0.97	0.00	0.58	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	147.59	27.15	25.18	0.91	2.12	1.52	0.30	0.00	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	314.86	59.06	46.20	0.31	0.31	0.31	2.75	0.61	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	314.08	47.32	41.60	1.53	1.91	2.67	3.05	0.76	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	314.54	34.29	31.86	3.51	3.51	3.78	1.08	0.27	1.08	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	113.65	26.09	15.89	1.16	0.70	0.81	0.46	0.12	0.12	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	91.41	13.71	11.38	2.43	0.88	0.33	0.33	1.22	0.55	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	88.59	7.72	6.91	0.20	0.00	0.41	0.00	0.20	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	26.73	7.35	9.35	0.00	0.00	0.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	110.70	21.74	20.56	1.19	0.40	0.00	1.19	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	400.86	51.60	45.44	1.39	3.77	4.37	1.79	1.79	1.39	2.98
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	740.85	78.68	69.27	4.97	4.62	3.91	6.57	2.31	3.20	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	587.12	61.88	47.50	4.93	4.14	3.74	7.10	6.11	0.79	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	266.86	35.20	33.39	1.81	2.71	0.60	0.90	0.00	0.60	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	616.62	92.19	76.11	1.94	2.37	5.51	3.56	2.81	1.84	3.45
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	382.14	47.83	39.23	1.52	3.04	3.54	2.53	6.58	1.52	1.52
Fibroblast - skin normal, donor1	11553-120C5	576.24	52.50	46.76	4.10	2.13	3.45	3.94	4.92	1.15	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	300.56	37.90	37.70	1.40	0.60	1.60	1.20	0.80	0.40	0.60
Fibroblast - skin normal, donor2	11561-120D4	513.06	55.96	44.81	1.61	3.11	3.52	1.31	3.62	0.70	2.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	460.91	57.12	55.31	2.42	3.02	6.35	2.72	1.81	1.81	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	767.49	62.38	52.44	6.13	2.98	2.40	11.02	5.88	1.41	2.73
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	173.69	50.26	24.96	1.20	1.03	1.03	0.17	0.68	0.17	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	487.72	45.00	56.16	0.99	2.63	2.63	2.30	0.99	0.33	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	554.02	56.99	55.92	2.34	3.30	4.58	3.94	2.45	1.07	3.52
Fibroblast - skin walker warburg, donor1	11554-120C6	361.15	31.04	25.47	2.53	2.19	1.18	1.18	0.84	0.34	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	260.79	37.64	23.21	5.96	3.61	4.70	3.92	6.43	7.06	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1373.91	332.40	177.28	22.16	44.32	132.96	22.16	44.32	66.48	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	6.97	0.87	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	52.53	14.91	7.80	0.87	0.17	0.00	0.00	0.00	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	62.46	16.13	8.85	0.78	0.26	0.00	0.00	0.00	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	51.10	16.10	12.52	0.51	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	19.90	12.25	6.89	2.30	0.00	0.77	0.00	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	21.69	13.40	8.29	1.28	1.28	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	25.10	21.11	15.12	3.42	2.28	2.28	0.00	0.00	0.00	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	27.02	40.81	29.78	2.76	1.10	1.93	0.00	0.00	1.38	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	34.02	32.42	16.21	2.28	0.91	1.14	0.00	0.00	1.14	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	21.00	19.42	12.09	2.18	1.19	1.59	0.00	0.00	0.59	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	27.49	30.93	21.15	4.49	1.59	1.06	0.00	0.00	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	34.90	40.44	19.24	2.28	0.33	0.98	0.00	0.00	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	25.65	15.04	9.29	3.10	0.88	2.21	0.00	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.95	21.76	14.27	0.14	0.57	0.99	0.00	0.00	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	25.98	28.20	17.73	0.99	0.86	1.85	0.00	0.00	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.92	20.42	10.21	0.81	0.81	0.54	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	56.50	35.56	24.78	0.99	0.50	1.12	0.00	0.00	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	48.59	34.47	22.01	0.69	1.52	0.83	0.00	0.00	0.42	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.95	21.35	11.59	1.02	1.02	1.42	0.00	0.00	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.30	28.52	15.74	0.68	0.91	0.91	0.00	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	43.10	31.14	19.06	1.12	1.25	1.25	0.00	0.00	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	42.40	23.17	18.58	0.22	0.87	0.66	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	39.59	37.82	13.89	2.07	1.18	1.18	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.14	39.58	23.05	1.11	2.54	2.23	0.00	0.00	0.95	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	44.24	26.59	15.42	2.01	0.89	0.45	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	55.45	29.64	18.55	0.81	0.81	2.02	0.00	0.00	1.01	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	49.03	44.45	23.24	1.70	1.87	1.02	0.00	0.00	1.19	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	93.11	39.19	15.69	1.06	0.89	0.53	0.00	0.00	0.53	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.49	39.96	20.39	0.73	0.21	0.31	0.00	0.00	0.52	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	77.19	46.79	25.62	1.02	0.34	0.17	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	39.84	33.86	20.80	0.77	1.11	1.00	0.00	0.00	0.44	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	75.04	38.27	18.80	1.00	0.67	0.25	0.00	0.00	0.42	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	92.09	40.22	17.36	0.61	0.82	0.41	0.00	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.91	31.56	16.71	3.09	1.24	0.62	0.00	0.00	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	46.92	35.86	23.06	1.27	1.96	1.96	0.00	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	53.70	25.85	13.67	0.67	0.83	0.67	0.00	0.00	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.47	20.94	13.89	0.66	0.66	0.88	0.00	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	31.49	29.40	22.63	0.86	0.74	1.23	0.00	0.00	0.49	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.82	28.37	14.91	0.65	1.30	0.97	0.00	0.00	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	32.71	27.26	14.11	1.92	1.60	0.64	0.00	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	29.47	25.49	15.54	1.14	0.85	0.85	0.00	0.00	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	46.35	21.67	13.60	0.79	1.27	0.63	0.00	0.00	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.36	24.33	13.68	0.61	1.22	0.30	0.00	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	38.89	29.38	16.41	1.05	1.15	1.15	0.00	0.00	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.64	19.76	12.30	0.44	0.44	0.44	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.16	30.30	7.86	0.28	0.56	0.00	0.00	0.00	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	46.20	23.98	13.70	0.56	0.74	0.37	0.00	0.00	0.09	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	36.10	15.51	9.09	0.53	1.34	1.87	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	47.74	17.75	8.72	0.77	0.92	1.07	0.00	0.00	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	45.21	23.58	13.86	1.04	0.52	0.52	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.43	16.54	8.67	0.54	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	71.53	29.86	14.01	0.55	2.03	0.74	0.00	0.00	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	77.86	30.05	14.91	0.88	2.41	0.88	0.22	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	55.54	18.84	13.88	0.00	0.00	0.00	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	108.04	36.14	17.28	1.71	1.85	1.06	0.26	0.00	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	86.96	32.68	14.53	1.01	0.40	1.01	0.61	0.00	0.61	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	149.19	42.70	29.48	0.51	0.25	0.00	0.25	0.25	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.52	24.88	16.52	0.00	0.60	0.20	0.00	0.00	0.60	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	7.40	16.95	11.56	0.62	0.77	0.62	0.00	0.00	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	15.14	26.80	16.16	0.41	1.02	0.82	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.40	19.40	8.45	0.00	0.31	0.00	0.00	0.00	0.31	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.41	14.69	8.19	1.13	0.00	0.00	0.00	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.53	28.13	15.68	1.38	0.46	0.92	0.00	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	17.32	17.32	0.00	7.42	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	32.11	27.85	13.15	1.16	0.39	1.55	0.00	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	9.63	6.42	1.60	1.60	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	33.04	20.87	3.48	1.74	3.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.57	22.46	7.81	3.58	1.95	0.65	0.00	0.00	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	34.59	30.47	7.41	4.94	2.06	1.24	0.00	0.00	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	33.32	10.00	0.00	10.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	53.97	29.08	17.90	2.24	1.68	1.12	0.00	0.00	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	52.95	26.15	16.34	1.96	1.96	1.63	0.00	0.00	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	53.69	35.23	16.78	3.36	3.36	7.55	0.00	0.00	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	62.98	35.62	22.58	3.82	2.23	0.95	0.00	0.00	0.64	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	62.84	24.12	9.51	2.04	1.70	1.02	0.00	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	48.03	18.79	29.23	0.00	4.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	62.42	30.93	22.34	5.15	2.29	0.57	0.00	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	46.77	14.21	13.02	2.07	0.59	0.89	0.00	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	103.34	25.41	8.47	3.39	3.39	3.39	0.00	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	88.64	25.68	16.57	2.49	5.38	2.49	0.00	0.00	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.26	29.23	16.57	2.76	2.30	0.92	0.00	0.00	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	89.56	21.07	15.81	15.81	10.54	0.00	0.00	0.00	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	70.35	30.37	11.53	3.84	1.15	0.38	0.00	0.00	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	61.61	19.88	14.02	1.63	0.98	1.96	0.00	0.00	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.86	14.71	15.38	2.01	1.34	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	59.72	17.34	20.80	1.93	1.16	0.39	0.00	0.00	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	80.79	22.59	18.14	2.40	1.03	1.37	0.00	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	17.39	14.91	4.97	2.48	7.45	0.00	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	57.09	21.71	21.23	3.30	0.47	1.42	0.00	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.30	18.71	18.71	4.22	1.21	2.41	0.00	0.00	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	54.94	26.45	18.31	2.54	1.53	1.02	0.00	0.00	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	52.65	32.70	23.13	1.99	0.80	1.60	0.00	0.00	1.60	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	49.83	24.67	22.69	1.48	1.97	2.47	0.00	0.00	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	68.47	22.43	27.15	9.44	3.54	3.54	0.00	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.59	19.84	20.42	1.75	1.17	2.33	0.00	0.00	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.83	17.12	25.02	1.76	0.88	0.88	0.00	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.95	13.56	17.80	5.09	0.00	2.54	0.00	0.85	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	41.78	14.92	13.13	1.79	2.39	1.19	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	56.29	15.53	12.62	1.94	1.46	0.97	0.00	0.00	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	188.31	46.79	14.84	1.14	0.00	0.00	0.00	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	128.90	45.74	14.97	1.66	5.82	4.99	0.42	0.42	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	85.46	9.00	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	159.85	55.19	31.08	3.49	2.85	4.44	3.17	0.00	0.63	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	141.20	25.48	18.38	2.92	2.09	2.92	4.18	0.42	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.42	7.08	4.53	0.23	0.46	0.35	0.00	0.00	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	18.57	9.96	4.39	0.17	0.84	0.51	0.00	0.00	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.47	7.28	5.23	0.23	0.46	0.23	0.00	0.00	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	13.34	6.56	3.72	0.33	0.66	0.33	0.00	0.00	0.11	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	15.04	7.74	5.80	0.21	0.21	0.43	0.00	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.42	6.67	3.44	0.65	0.22	0.22	0.00	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	10.34	3.99	4.73	0.25	0.62	0.25	0.00	0.00	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	13.72	7.38	3.77	0.00	0.51	0.51	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.61	3.20	3.20	0.00	0.00	0.32	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.18	4.48	2.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.34	1.30	3.46	0.43	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	63.45	18.51	0.00	2.64	5.29	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	54.67	7.76	8.82	0.00	0.00	0.00	0.00	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	40.68	5.81	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	58.05	11.19	6.82	1.22	1.57	0.52	0.35	0.35	0.35	0.00
Hepatocyte, donor1	11523-119I2	39.95	14.53	6.05	2.42	1.21	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	30.17	10.77	5.39	2.15	1.08	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	34.97	15.95	3.68	0.61	1.23	0.61	0.00	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	15.01	2.61	1.96	0.00	0.00	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	42.82	11.36	7.87	1.22	0.35	0.87	0.00	0.00	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	40.89	33.20	14.00	0.96	0.41	0.69	0.00	0.00	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	6.37	6.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	4.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	5.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	4.87	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	3.97	3.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	2.22	3.33	0.00	0.00	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	3.15	3.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	0.00	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.75	3.88	1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	3.22	4.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	1.63	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.98	2.10	1.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	0.80	2.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	3.78	2.36	0.00	0.00	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	5.44	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	18.29	4.30	1.08	1.08	1.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	1.27	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	9.57	3.19	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	1.82	7.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	5.71	2.86	0.00	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	3.32	9.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.41	4.63	3.40	0.31	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	7.02	3.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	9.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	8.34	4.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	6.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	4.36	0.00	0.00	0.00	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	4.50	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	4.27	5.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	2.77	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	2.85	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	5.52	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	9.08	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	3.17	1.06	0.00	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	44.63	10.77	4.41	0.65	0.33	0.24	0.00	0.00	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	7.61	1.76	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	21.11	7.76	3.50	0.09	0.28	0.38	0.00	0.00	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	28.72	16.57	9.31	0.23	0.45	0.68	0.00	0.00	0.68	0.23
Keratocytes, donor1	11527-119I6	46.42	11.69	7.91	0.34	0.00	0.00	0.34	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	23.44	7.03	5.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	39.91	24.11	13.63	0.59	0.79	0.79	0.00	0.00	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	48.35	13.19	19.78	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	31.28	14.02	7.55	2.16	2.16	2.16	0.00	0.00	2.16	1.08
Lens Epithelial Cells, donor2	11609-120I7	29.29	48.32	22.95	0.35	0.35	0.35	0.00	0.00	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	191.83	61.66	38.85	0.10	1.11	0.10	0.30	1.11	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	41.50	9.37	8.18	0.59	0.24	0.24	0.00	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.88	6.14	2.79	0.56	0.28	1.40	0.00	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	47.54	10.55	7.87	1.42	1.73	2.05	0.00	0.00	0.16	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	28.50	8.07	4.84	1.61	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.28	2.21	2.21	0.32	0.63	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	17.14	4.64	2.59	0.54	0.32	0.43	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	53.76	7.80	4.92	0.41	0.41	0.41	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.38	2.28	2.28	0.25	0.00	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.30	3.94	3.10	0.42	0.99	0.84	0.00	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	38.37	6.33	4.75	0.40	0.79	0.40	0.00	0.00	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	31.02	5.62	5.82	0.78	0.78	0.39	0.00	0.00	0.19	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.92	1.67	1.85	0.00	0.56	0.37	0.00	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	39.02	7.67	6.62	0.35	1.05	1.39	0.00	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.91	5.01	4.29	0.48	0.00	0.72	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.82	4.67	2.75	0.55	0.41	0.27	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	43.42	8.31	7.70	0.62	1.54	0.31	0.00	0.00	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.16	2.81	1.87	0.31	0.00	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.48	4.57	2.74	0.00	0.37	0.55	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.58	7.57	4.94	0.33	0.00	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	20.21	2.64	1.17	0.59	0.29	0.88	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.94	2.24	1.49	0.25	0.00	0.00	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	35.40	8.24	6.79	0.48	1.45	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	28.55	4.85	5.92	0.81	0.54	0.81	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	27.10	6.51	3.48	0.30	0.45	0.30	0.00	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.03	4.15	6.22	0.52	0.00	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	39.99	7.54	4.40	1.05	0.42	0.00	0.00	0.00	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.05	6.17	2.86	1.20	1.50	0.15	0.00	0.00	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	33.71	5.50	4.13	0.69	0.69	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	26.91	6.40	3.57	0.19	0.56	0.75	0.00	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	15.06	4.77	2.12	0.21	0.42	0.42	0.00	0.00	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	35.86	6.78	6.78	0.97	0.97	0.48	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	28.45	3.64	1.98	0.33	0.66	0.99	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	16.85	5.95	1.61	0.12	0.25	0.74	0.00	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	42.94	12.96	8.51	1.48	0.00	0.74	0.37	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	32.61	6.42	2.96	1.98	0.00	0.74	0.00	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	15.12	3.71	2.47	0.41	0.55	0.14	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	47.28	5.79	10.94	1.29	0.00	0.96	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	50.21	5.78	3.96	0.91	1.22	0.61	0.00	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.25	7.84	6.02	1.26	0.84	0.70	0.00	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	34.13	8.89	7.82	0.71	0.36	0.00	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.51	0.97	1.94	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.27	2.49	1.56	0.16	0.16	0.00	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	31.51	6.45	5.37	0.72	0.36	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	28.09	3.59	3.59	0.65	0.00	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.83	1.41	0.47	0.71	0.00	0.00	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	42.82	10.77	5.82	0.00	0.50	0.50	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.88	1.54	2.05	0.51	0.00	0.26	0.00	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.92	3.58	4.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.21	4.60	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	1.48	1.48	0.00	0.00	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	2.54	1.27	0.42	0.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	1.41	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	2.80	2.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.76	3.61	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	3.57	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.01	2.26	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.41	2.33	1.74	0.87	0.29	0.58	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	5.40	3.60	0.90	0.00	0.00	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.30	3.12	2.17	0.14	0.14	0.14	0.00	0.00	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.24	2.57	2.05	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.00	2.12	3.18	0.35	0.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.33	4.00	2.67	0.00	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	3.57	2.04	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.81	3.47	3.20	0.53	0.27	0.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.23	5.48	1.70	0.19	0.38	0.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.34	0.61	0.00	0.00	0.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	4.08	2.45	0.00	1.63	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.45	6.04	4.58	0.62	0.21	0.62	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	17.66	3.64	1.68	0.56	0.28	1.12	0.00	0.00	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	2.06	1.03	0.00	0.00	1.03	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	16.26	5.23	1.74	0.87	0.87	0.00	0.29	0.00	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.94	4.78	1.49	0.30	0.00	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.04	4.43	1.66	0.00	0.00	0.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	11.67	2.47	2.83	0.35	0.00	0.35	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	5.16	1.48	0.00	0.37	1.11	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	2.30	3.45	0.00	0.00	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.90	4.61	1.54	0.38	1.15	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.19	2.26	1.70	0.00	0.57	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	4.10	2.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	2.26	2.26	0.45	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	1.44	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	6.72	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.78	3.34	2.60	0.37	0.74	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.95	1.72	1.29	0.00	0.00	0.43	0.00	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	3.43	0.00	0.00	0.00	0.00	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	3.33	3.66	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.88	3.62	0.00	1.21	0.00	0.60	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	3.55	2.13	3.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.97	3.09	1.37	0.69	0.34	0.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.90	3.22	0.54	0.54	0.00	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.14	3.37	3.37	0.67	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.15	2.59	2.22	0.00	0.37	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	3.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	1.06	1.06	0.00	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.80	2.80	3.20	0.40	0.40	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	3.63	0.73	0.00	0.73	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	7.67	1.53	1.53	0.00	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	10.85	4.44	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	2.82	0.94	0.00	0.94	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	10.06	2.51	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	2.70	1.80	0.00	0.90	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.02	4.45	3.12	0.00	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.21	2.74	3.13	0.39	0.39	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.83	1.98	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.78	3.11	1.04	0.52	0.52	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.94	5.25	1.75	0.00	0.44	0.44	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.39	2.80	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.72	2.21	3.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.43	3.09	1.54	0.77	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.63	2.03	0.00	0.51	0.51	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.53	2.88	3.36	0.00	0.00	0.48	0.00	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.14	1.19	3.58	0.40	0.40	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.76	3.04	3.65	1.22	0.61	1.22	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	0.69	1.38	0.00	0.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.64	2.28	1.14	0.38	0.76	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.98	3.10	0.52	0.00	0.00	1.03	0.00	0.00	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	1.21	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.68	1.90	1.58	0.32	0.00	0.00	0.00	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.13	3.20	1.07	0.00	0.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	2.30	2.30	0.00	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.26	0.51	5.14	0.00	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15.56	4.24	2.12	0.00	0.71	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.21	3.40	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.14	2.91	2.50	0.00	0.00	1.25	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	3.92	2.35	0.78	0.00	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.86	2.92	2.92	0.00	0.00	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.83	3.25	3.25	0.00	0.00	0.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	5.35	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.23	4.28	1.60	0.00	0.00	0.00	0.00	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.53	3.64	2.83	0.00	0.00	0.00	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	0.92	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	3.56	0.89	0.00	0.00	0.00	0.00	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	12.54	4.56	0.00	0.00	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	10.74	2.30	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.75	4.92	0.00	0.55	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	3.12	2.23	0.00	0.00	1.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.08	2.86	1.30	0.26	0.26	0.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	10.61	4.64	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	2.08	0.00	0.00	0.00	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	20.97	7.07	5.01	1.37	0.00	0.23	0.00	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	44.41	9.54	6.06	0.73	0.73	0.37	0.00	0.00	0.18	0.92
Macrophage - monocyte derived, donor3	11389-118C3	44.70	10.88	8.26	0.00	0.92	0.26	0.00	0.00	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	63.72	13.81	5.84	0.53	0.00	0.00	0.00	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	88.42	19.17	11.73	0.48	0.48	0.48	0.16	0.00	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	75.47	17.51	12.23	0.97	0.56	0.28	0.00	0.00	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	67.06	19.23	12.56	1.69	0.40	1.10	0.00	0.00	0.20	0.40
Mammary Epithelial Cell, donor2	11350-117G9	72.10	19.11	8.69	0.87	1.16	1.74	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	21.45	6.73	4.74	0.00	0.25	0.00	0.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	419.64	90.84	67.12	0.68	0.68	2.71	0.00	0.00	0.68	0.68
Mast cell, donor1	11563-120D6	144.58	42.07	26.39	1.19	0.43	0.87	0.00	0.00	0.32	0.11
Mast cell, donor2	11565-120D8	293.01	62.41	46.36	1.49	1.49	0.59	0.30	0.00	0.30	1.19
Mast cell, donor3	11566-120D9	312.70	53.35	51.55	4.05	2.03	1.35	0.00	0.00	0.23	1.80
Mast cell, donor4	11567-120E1	376.38	60.99	56.91	3.37	1.60	0.18	0.00	0.18	0.53	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	90.38	35.15	18.41	1.00	1.77	0.67	0.00	0.00	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	143.00	14.01	6.42	1.17	0.58	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	99.35	40.50	22.60	1.03	0.80	0.57	0.00	0.00	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	97.24	27.11	12.72	1.34	0.50	0.33	0.00	0.00	0.17	0.67
Melanocyte - dark, donor1	11502-119F8	77.71	20.00	13.43	0.50	0.00	0.40	0.00	0.00	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	33.57	10.38	4.15	1.04	0.00	0.35	0.00	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	39.63	21.95	14.13	0.58	0.43	0.36	0.14	0.07	0.29	0.14
Melanocyte - light, donor1	11274-116H5	11.05	5.17	2.35	0.00	0.00	0.00	0.00	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	8.19	4.09	4.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	15.61	6.07	4.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	26.14	12.18	10.72	0.52	0.52	0.73	0.00	0.00	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	49.75	7.53	6.19	2.15	0.00	1.34	0.00	0.00	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	24.37	8.84	8.30	1.07	0.80	0.00	0.00	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	95.65	60.91	17.99	0.12	0.25	0.50	0.00	0.00	0.25	0.87
Meningeal Cells, donor2	11573-120E7	44.01	40.93	12.76	0.00	0.88	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	164.47	95.44	22.09	1.22	0.73	1.14	0.16	0.00	0.98	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	76.42	20.53	14.83	1.14	0.00	0.29	0.00	0.00	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	163.93	19.12	9.36	1.71	0.50	0.81	0.70	0.70	0.00	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	5.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	2.62	6.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	54.54	13.63	6.46	1.44	0.72	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	390.29	28.38	23.51	1.27	2.54	1.91	1.27	1.06	0.85	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	201.56	17.59	19.60	1.01	1.01	4.02	0.50	1.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	41.75	7.91	4.40	0.22	0.22	0.22	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.76	4.38	2.92	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	23.32	2.05	4.50	0.00	0.00	0.20	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	128.40	32.83	26.87	1.39	0.69	0.14	1.25	0.42	0.69	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	33.83	2.97	2.60	0.00	0.00	0.74	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	163.42	25.92	23.03	1.45	1.05	1.32	1.05	0.79	0.66	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	40.06	4.75	4.75	0.00	0.59	0.30	0.00	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	4.67	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	58.28	6.40	5.12	1.28	0.00	0.00	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	73.72	19.49	11.70	1.42	0.35	0.00	0.71	0.00	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	129.47	19.39	21.89	2.50	0.63	0.63	0.63	1.25	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	74.75	13.79	8.71	2.18	2.18	0.73	1.45	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	67.09	13.26	6.63	0.27	0.53	0.00	0.00	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	73.07	16.01	8.01	0.50	0.00	0.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	50.08	10.19	6.94	0.51	0.65	1.23	0.07	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	63.47	9.45	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	56.40	11.08	6.90	0.74	1.48	1.23	0.00	0.00	0.25	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	70.96	8.54	7.36	0.88	1.18	0.88	0.00	0.00	0.29	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	72.60	3.46	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	41.22	8.37	5.58	0.31	0.62	0.31	0.00	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.95	8.92	4.77	0.41	1.24	1.66	0.00	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	64.85	6.95	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	44.55	10.01	6.51	0.50	0.50	1.00	0.00	0.00	0.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	87.51	11.64	3.72	0.00	0.00	0.00	0.00	0.00	0.00	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	38.20	7.52	5.69	0.61	0.00	0.81	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	64.94	7.13	5.15	0.79	0.00	0.00	0.00	0.00	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	128.27	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	25.66	6.19	6.19	0.00	0.00	0.88	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	55.09	8.36	4.18	3.42	0.00	1.90	0.00	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	89.48	3.95	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.53	5.09	5.31	0.21	0.21	0.85	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	73.67	6.45	6.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	46.20	6.26	5.96	0.30	0.60	0.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	62.04	6.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	45.92	6.77	5.52	0.75	1.00	0.75	0.25	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	64.88	8.32	5.23	0.71	1.43	1.90	0.00	0.00	0.24	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	105.60	7.19	4.42	1.11	0.55	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	59.40	5.30	3.91	0.92	1.15	0.92	0.00	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	87.92	6.52	5.68	0.84	1.05	0.63	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	82.35	8.36	8.36	0.41	1.02	1.22	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	50.63	7.08	4.29	1.29	0.64	0.43	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	95.59	10.23	5.56	0.22	0.00	0.44	0.00	0.00	0.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	144.46	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	59.35	6.13	3.29	0.44	0.66	0.88	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	96.32	8.11	5.07	0.51	0.00	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	81.19	8.28	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	79.36	6.79	4.89	0.54	0.82	0.82	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	108.52	8.23	6.47	0.59	0.29	0.59	0.00	0.00	0.29	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	76.32	2.18	2.18	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	37.48	2.40	4.32	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	106.06	6.80	6.40	2.00	1.20	0.80	0.00	0.00	0.00	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	101.47	6.86	4.11	2.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	57.57	4.51	4.00	0.50	1.50	1.50	0.00	0.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	99.89	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	59.56	5.69	7.01	1.75	0.44	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	96.02	3.31	2.21	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	79.41	7.68	5.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	58.01	5.45	5.45	1.24	0.50	0.74	0.00	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	91.86	4.87	4.87	1.39	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	114.91	0.00	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	56.07	4.79	8.21	0.68	0.68	0.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	77.90	7.00	7.88	0.00	0.00	0.88	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	60.37	5.68	6.39	0.36	0.36	0.00	0.00	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	63.97	6.45	5.61	0.28	0.28	0.84	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	80.63	7.90	7.07	0.42	0.42	0.42	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	67.02	2.91	4.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	58.82	8.75	3.92	1.21	0.30	1.21	0.00	0.00	1.21	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	68.45	6.68	7.93	0.42	0.83	1.25	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	93.84	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	74.81	7.39	3.69	0.00	1.85	2.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	71.14	3.41	6.26	0.57	1.14	0.00	0.00	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	56.38	8.15	7.88	0.00	0.41	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	63.49	8.55	5.96	1.81	0.26	1.55	0.00	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	66.92	9.01	6.01	0.00	0.86	0.00	0.00	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	76.86	6.35	6.99	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	72.59	10.14	6.67	0.53	0.80	0.80	0.00	0.00	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	47.59	6.88	5.69	0.60	0.90	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	43.65	6.07	4.94	0.00	0.28	0.28	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	53.83	5.41	5.41	1.59	0.32	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.39	4.64	2.87	0.22	0.22	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	70.15	6.07	4.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	72.45	7.10	4.83	1.42	1.14	0.57	0.00	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	46.46	6.15	4.42	0.98	0.74	0.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	61.91	7.17	6.52	0.65	0.00	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	57.92	8.82	10.00	1.47	0.29	0.88	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	45.56	9.51	4.90	1.15	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	60.17	11.54	5.36	0.41	0.41	0.41	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	53.90	9.53	4.17	0.30	0.30	0.30	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	3.56	0.00	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.06	6.57	2.63	0.00	0.00	0.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	6.31	6.31	2.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.33	7.51	1.78	0.40	0.00	0.00	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.98	7.45	10.24	0.00	0.00	0.00	0.00	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	18.78	5.63	4.88	0.75	0.00	0.75	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.11	5.59	3.73	0.27	0.00	0.27	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.70	4.52	2.60	0.23	0.34	0.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	2.21	2.21	0.74	0.00	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.95	7.69	2.93	0.00	0.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	6.22	4.67	3.11	1.56	3.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.03	3.21	3.21	1.07	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	15.46	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	3.03	3.03	0.00	0.00	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.08	5.90	3.37	0.00	0.42	0.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	35.41	4.09	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.98	3.81	2.54	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	7.29	4.05	0.00	0.00	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	1.51	1.51	0.00	0.00	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	365.45	11.42	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	202.27	9.79	13.05	0.00	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	250.12	46.10	24.78	2.80	1.94	1.72	1.94	10.13	0.65	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	153.65	46.51	20.38	1.05	4.70	1.05	2.61	3.66	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	47.39	26.70	6.01	1.33	0.00	0.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	104.34	20.45	8.76	0.42	0.00	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	110.47	47.73	21.87	1.14	0.38	0.19	1.33	0.00	0.19	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	181.93	78.20	33.51	3.19	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	52.36	15.64	4.08	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	117.61	47.78	20.21	0.00	3.68	5.51	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	57.34	23.86	5.02	1.26	0.42	0.00	0.84	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	109.48	29.98	11.62	1.39	0.23	0.23	0.46	0.00	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	76.20	23.78	10.27	0.54	0.54	0.54	0.54	0.27	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	124.25	39.94	20.18	1.47	0.42	0.84	1.05	0.00	0.21	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	356.31	189.29	22.27	0.00	22.27	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	62.04	21.34	8.44	1.99	0.00	1.49	0.00	0.00	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	109.62	39.52	11.91	1.35	0.00	0.27	1.62	0.27	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	96.34	24.25	10.43	0.45	0.68	0.45	1.81	0.23	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	125.74	33.64	9.96	0.65	0.00	0.16	1.80	0.16	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	134.50	51.94	15.49	1.09	2.00	2.37	2.55	0.55	0.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	93.89	27.58	7.96	0.53	1.59	0.53	1.06	0.53	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	117.06	27.61	7.20	2.40	0.60	0.00	0.60	0.60	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	202.81	61.04	23.96	4.27	2.30	3.61	4.59	1.97	2.95	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	137.09	27.16	11.87	0.81	0.00	0.16	1.30	0.33	0.98	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	208.48	59.09	20.64	2.65	1.76	2.12	2.47	1.06	0.53	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	97.75	30.94	9.85	0.70	0.70	1.41	0.70	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	176.99	35.86	17.47	0.46	0.46	0.46	0.92	0.00	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	150.39	42.10	16.07	0.32	1.29	0.64	2.57	0.64	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	215.90	76.91	35.18	7.59	5.17	1.72	13.80	4.83	6.21	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	460.18	197.22	88.50	0.00	12.64	20.23	15.17	12.64	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	192.71	55.70	22.95	1.56	1.11	0.67	2.01	0.89	0.00	2.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	148.61	34.29	12.70	2.96	2.54	0.42	1.69	0.42	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	195.58	41.54	17.80	1.19	0.47	0.47	0.24	0.00	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	165.26	50.65	15.88	1.29	0.86	0.00	3.00	0.86	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1182.64	279.86	153.47	9.03	54.17	108.33	27.08	18.06	27.08	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	167.28	46.32	22.33	1.00	0.67	0.67	0.67	0.67	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	236.70	38.77	17.58	1.80	0.00	0.45	1.80	0.90	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	153.56	25.00	12.70	3.17	0.79	0.00	3.17	2.78	1.59	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	130.01	20.43	7.43	0.93	0.93	0.93	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	228.92	47.30	32.92	2.27	0.76	0.38	1.89	1.51	2.27	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	235.62	37.15	14.99	3.58	0.65	1.63	2.61	2.28	2.93	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	156.45	32.68	19.17	0.00	0.00	0.44	1.74	0.44	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	332.43	67.84	26.68	2.71	1.81	1.81	3.62	0.90	0.45	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	162.27	16.76	11.46	0.00	0.88	0.00	3.53	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	156.90	39.89	14.63	3.99	1.99	0.00	0.66	0.66	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	220.24	39.19	16.37	2.48	2.48	0.99	1.98	0.99	2.48	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	208.64	27.95	18.38	4.21	0.77	0.77	1.91	1.91	2.30	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	234.40	66.54	30.55	1.51	0.00	0.60	1.51	1.51	1.81	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	280.92	45.31	24.31	2.87	1.77	1.99	5.08	1.77	0.66	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	193.13	40.66	13.55	4.74	0.68	0.68	2.03	2.03	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	464.97	183.94	35.77	15.33	15.33	20.44	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	205.46	51.21	15.85	1.83	2.44	0.00	3.05	0.61	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	246.44	29.27	20.77	2.20	0.00	1.26	2.20	1.26	2.52	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	160.10	43.58	14.22	1.51	0.61	0.91	0.30	0.61	2.42	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	160.60	33.23	18.99	0.79	0.00	0.00	3.16	1.58	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	309.48	61.22	40.81	10.20	6.80	7.94	11.34	2.27	5.67	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	303.47	131.51	50.58	0.00	15.17	20.23	15.17	0.00	20.23	5.06
Myoblast, donor1	11241-116D8	168.95	21.86	13.79	3.48	1.12	1.37	2.86	0.62	0.75	0.50
Myoblast, donor2	11322-117D8	80.36	23.40	13.04	0.58	2.11	1.15	0.58	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	205.49	37.00	25.73	1.18	0.67	0.84	1.51	0.17	0.34	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.64	9.63	6.71	0.44	0.73	0.73	0.00	0.00	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	39.98	8.30	5.54	0.31	0.00	0.00	0.00	0.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	26.54	4.82	3.92	0.60	1.21	0.30	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	40.68	7.91	4.42	0.55	0.37	0.00	0.00	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	146.63	124.49	22.14	0.73	1.45	3.27	0.00	0.00	0.00	0.36
Neural stem cells, donor2	11352-117H2	298.47	117.46	65.47	0.00	1.93	0.00	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	124.03	95.58	28.45	3.41	1.14	1.14	0.00	0.00	1.14	0.00
Neurons, donor2	11574-120E8	93.79	57.02	25.54	0.88	0.88	1.76	0.22	0.00	0.22	1.10
Neurons, donor3	11655-122E8	99.48	50.15	18.09	1.64	4.93	2.47	0.00	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	2.78	1.86	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.89	1.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	81.45	44.17	19.35	1.19	0.71	0.71	0.24	0.00	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	24.75	16.28	5.54	1.95	0.98	0.00	0.00	0.00	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	63.37	27.68	14.24	1.00	1.00	0.80	0.20	0.00	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	142.06	27.12	14.87	1.79	2.75	2.20	3.17	1.24	0.14	0.41
Olfactory epithelial cells, donor2	11934-125I8	285.58	39.80	24.17	7.24	13.03	8.11	9.41	4.20	3.47	1.45
Olfactory epithelial cells, donor3	11935-125I9	260.38	34.16	21.68	5.45	3.18	2.84	6.92	3.63	1.14	0.79
Olfactory epithelial cells, donor4	11936-126A1	195.28	40.61	22.40	2.43	2.14	2.14	4.77	1.07	0.19	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	87.26	10.83	18.05	1.20	0.60	1.20	0.00	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	168.03	25.52	17.44	0.64	0.43	0.43	1.28	0.64	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	57.16	17.15	6.86	2.29	0.00	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	32.28	14.90	6.83	0.00	0.00	0.00	0.00	0.00	1.24	0.00
Osteoblast, donor1	11277-116H8	45.54	6.64	4.30	0.20	0.20	0.39	0.20	0.98	0.00	0.00
Osteoblast, donor2	11354-117H4	237.38	37.22	22.47	0.70	2.11	3.51	2.11	3.51	0.00	0.70
Osteoblast, donor3	11426-118G4	142.18	18.48	21.86	0.89	0.71	0.89	0.71	1.78	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	392.12	55.26	40.94	4.63	3.20	2.02	4.63	0.84	1.26	0.67
Pericytes, donor1	11491-119E6	8.57	10.57	3.89	0.11	0.00	0.11	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	9.05	9.51	3.17	0.00	0.00	0.23	0.00	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	44.35	9.77	4.68	0.81	0.00	0.81	0.41	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	107.60	101.72	39.44	1.47	0.57	0.79	1.36	0.79	1.02	0.34
Perineurial Cells, donor2	11579-120F4	44.81	17.39	8.83	0.55	0.28	0.09	0.00	0.00	0.00	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.30	4.14	2.23	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	9.30	3.18	0.73	0.00	0.00	0.73	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	9.97	3.11	2.20	0.39	0.13	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	33.96	4.07	3.11	0.24	0.24	0.00	0.00	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	109.78	12.20	12.20	3.33	1.11	1.11	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	56.35	5.89	6.87	0.39	0.59	0.00	1.96	0.20	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	268.04	23.42	17.72	5.06	2.53	3.48	0.63	1.27	2.85	0.95
Preadipocyte - breast, donor1	11467-119B9	403.13	30.76	12.76	3.94	3.19	0.75	3.19	9.00	0.75	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	519.89	46.86	51.04	1.96	1.17	1.31	2.22	3.39	0.65	0.13
Preadipocyte - breast, donor2	11328-117E5	331.42	27.69	23.64	6.75	3.83	4.50	1.58	2.03	2.48	1.58
Preadipocyte - omental, donor1	11468-119C1	325.75	32.18	13.85	3.62	2.13	1.28	2.34	11.30	0.43	1.07
Preadipocyte - omental, donor2	11329-117E6	529.44	52.81	27.93	4.80	2.18	2.18	0.44	3.49	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	348.09	25.36	22.92	6.02	2.86	4.15	0.72	7.88	2.15	1.00
Preadipocyte - perirenal, donor1	11469-119C2	84.65	11.81	12.80	0.00	2.95	0.98	0.00	2.95	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	66.34	9.83	4.30	0.00	0.00	0.00	0.61	1.54	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	115.45	24.61	12.22	2.12	2.48	2.83	0.18	0.18	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	61.47	23.33	11.92	0.34	0.85	1.02	0.51	1.02	0.68	0.17
Preadipocyte - visceral, donor1	11280-116I2	141.12	29.90	14.07	1.02	0.56	0.75	0.65	0.37	0.28	0.19
Preadipocyte - visceral, donor2	11357-117H7	95.72	28.99	7.36	0.00	4.14	1.84	0.00	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	64.58	17.03	9.93	1.36	1.36	1.57	0.21	0.10	0.21	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	56.27	9.96	8.90	1.06	0.60	0.30	0.00	0.00	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	42.38	12.46	8.53	1.22	0.95	1.49	0.00	0.00	0.54	0.14
Prostate Epithelial Cells, donor3	11404-118D9	13.29	6.61	4.29	0.31	0.61	0.55	0.00	0.00	0.43	0.00
Prostate Stromal Cells, donor1	11254-116F3	130.07	18.91	14.35	2.39	1.14	0.80	1.14	3.76	0.23	0.46
Prostate Stromal Cells, donor2	11332-117E9	112.42	26.00	13.09	2.15	2.69	2.33	0.72	0.54	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	48.07	18.77	10.32	1.04	0.94	0.83	0.31	0.21	0.73	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.61	3.65	4.01	0.00	0.36	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	78.18	15.87	11.92	0.90	0.90	0.55	0.00	0.00	0.42	0.21
Renal Epithelial Cells, donor1	11517-119H5	15.72	4.06	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.25	2.85	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	66.06	18.31	11.43	1.48	0.11	0.42	0.00	0.00	0.42	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.85	4.09	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.73	4.72	3.50	0.13	0.40	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	130.99	17.54	17.32	1.33	3.11	4.44	0.22	0.22	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	2.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	31.25	6.16	4.18	0.22	0.44	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	25.08	3.13	3.76	0.00	0.63	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.59	0.83	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	37.31	6.44	4.56	0.54	0.27	0.27	0.00	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.07	3.37	4.64	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	27.38	4.44	4.05	0.19	0.00	0.19	0.00	0.00	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	25.15	9.33	9.59	1.04	0.00	0.26	0.00	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	8.24	1.42	2.27	0.28	0.28	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	3.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	21.58	4.27	1.25	0.00	0.00	0.00	0.25	0.00	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	60.27	22.32	10.16	0.94	1.07	0.27	0.00	0.00	0.27	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	55.39	21.44	15.19	0.00	0.00	2.68	4.47	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.92	19.81	11.56	2.20	3.85	3.85	6.60	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	81.21	31.32	16.24	1.74	2.32	2.32	2.90	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	127.42	49.80	37.06	1.04	1.82	0.91	4.94	0.26	0.00	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	92.06	28.60	19.66	0.79	1.89	2.68	4.77	0.10	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	144.67	39.04	25.88	1.12	0.78	0.56	7.25	0.33	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	112.26	48.13	35.10	1.36	3.10	1.98	6.57	0.12	1.12	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	86.71	29.49	18.76	1.05	1.86	2.45	5.71	0.12	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	125.50	33.98	23.58	0.46	1.62	4.85	7.63	0.00	0.69	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	93.78	34.77	28.07	0.41	1.64	2.05	3.29	0.00	0.55	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	89.55	25.11	22.24	1.06	3.63	4.54	5.75	0.30	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	137.44	34.40	27.77	1.08	0.18	0.18	5.20	0.18	0.18	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	87.22	36.01	26.54	0.29	1.72	1.43	3.01	0.14	0.57	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	80.38	29.51	18.57	0.43	2.25	1.93	5.37	0.43	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	99.13	28.54	17.70	1.99	2.21	1.55	6.64	0.22	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	112.03	40.34	30.40	0.76	2.49	0.96	2.29	0.19	0.00	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	91.39	30.84	19.66	0.84	1.21	2.05	4.19	0.37	0.19	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	187.34	43.78	19.73	1.13	2.44	1.69	9.58	0.00	0.19	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	100.86	40.48	29.73	0.80	0.93	1.46	2.92	0.53	0.27	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	97.15	35.53	23.26	0.78	1.95	2.43	6.72	0.10	0.58	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	110.76	27.31	20.43	0.95	2.29	1.34	6.49	0.00	0.95	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	97.29	37.27	27.55	0.53	1.60	1.92	2.46	0.21	0.43	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	95.58	26.35	14.30	2.24	2.24	3.08	5.89	0.00	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	123.73	35.55	19.48	0.85	1.88	2.91	6.49	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	100.65	40.30	26.80	0.00	1.82	2.37	3.10	0.18	0.18	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	81.43	27.10	18.27	1.10	1.96	2.08	3.19	0.25	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	105.84	30.76	23.24	1.75	1.88	1.34	7.52	0.00	0.27	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	95.53	41.75	26.89	1.18	1.18	1.89	3.77	0.47	0.24	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	88.10	28.17	19.05	0.60	1.98	2.18	4.37	0.00	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	108.04	26.66	19.18	0.47	1.17	1.64	5.38	0.23	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	89.16	34.21	28.20	1.24	2.28	0.83	2.49	0.41	0.21	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	104.63	36.72	15.48	0.44	3.54	1.99	5.31	0.44	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	109.66	32.17	18.17	1.67	1.25	0.84	6.27	0.00	0.42	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	93.13	40.51	28.40	0.54	2.56	1.88	4.17	0.54	0.67	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	102.18	31.85	23.50	0.34	0.17	0.68	3.41	0.51	0.17	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	104.88	34.51	21.59	1.54	1.35	2.51	5.40	0.19	0.77	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	93.36	43.84	29.75	0.69	2.41	2.06	4.81	0.52	0.52	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	88.20	28.26	20.44	1.23	0.69	0.55	3.98	0.14	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	100.31	34.64	18.72	0.99	2.96	2.63	5.75	0.33	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	102.43	39.88	28.29	1.53	1.53	2.22	2.22	0.17	0.51	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	111.41	31.51	22.64	1.18	1.92	1.78	6.51	0.15	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	123.68	31.72	21.06	1.60	1.87	0.80	6.13	0.27	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	72.18	34.29	25.58	0.28	1.52	0.83	0.97	0.00	0.41	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	96.67	30.00	24.29	1.67	1.19	2.14	2.14	0.00	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	150.15	38.49	29.02	0.60	2.02	0.81	2.82	0.00	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	82.21	33.06	23.92	0.57	0.66	1.22	1.51	0.00	0.28	2.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	62.54	27.25	18.87	1.40	3.84	2.79	4.19	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	63.46	23.27	16.62	0.60	0.91	0.60	6.35	0.00	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	61.56	28.88	22.03	0.49	1.47	1.59	2.33	0.00	0.37	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	143.22	54.73	28.09	0.73	0.44	0.15	12.37	0.00	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	73.62	22.51	25.55	0.61	0.61	0.00	2.43	0.00	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	70.83	29.54	25.92	1.51	1.51	0.30	1.51	0.00	0.30	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.92	26.46	13.35	1.36	1.81	0.45	2.04	0.00	0.68	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	62.30	22.47	17.37	2.10	1.50	0.30	3.29	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	51.36	33.53	18.77	0.83	1.30	0.94	2.83	0.12	0.00	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	44.82	18.14	11.10	1.07	0.21	0.64	2.13	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	61.90	31.25	19.83	0.00	0.60	1.20	4.21	0.00	0.60	1.20
Schwann Cells, donor1	11498-119F4	14.86	7.90	4.51	0.38	0.00	0.00	0.00	0.00	0.38	0.00
Schwann Cells, donor2	11578-120F3	57.84	27.22	10.21	3.40	0.00	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	86.32	34.40	17.09	2.85	2.63	2.41	0.44	0.00	1.53	0.00
Sebocyte, donor1	11220-116B5	58.06	9.31	13.15	0.00	0.00	0.00	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	18.84	6.89	2.76	0.46	0.92	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	28.03	8.66	6.80	0.00	1.24	0.21	0.00	0.00	0.21	0.21
Sertoli Cells, donor1	11255-116F4	46.38	11.60	6.63	0.00	0.00	0.00	0.00	8.28	0.00	0.00
Sertoli Cells, donor2	11333-117F1	104.50	31.07	5.65	2.82	0.00	5.65	0.00	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	61.50	19.36	7.39	0.44	0.18	0.18	1.14	0.35	0.18	0.18
Skeletal Muscle Cells, donor2	11358-117H8	31.08	3.61	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	48.49	7.52	10.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	45.71	17.75	11.15	0.47	0.47	0.31	0.00	0.00	0.31	0.63
Skeletal Muscle Cells, donor5	11455-119A6	52.03	20.66	9.22	0.59	0.74	0.30	0.15	0.00	0.15	0.30
Skeletal Muscle Cells, donor6	11459-119B1	102.81	24.16	20.01	0.77	0.77	1.54	0.62	0.31	0.77	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	127.39	29.61	17.51	2.14	1.01	0.76	2.27	0.25	0.13	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	77.05	19.12	10.99	0.57	1.43	0.86	0.29	0.00	0.57	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	112.50	26.19	18.16	0.60	0.89	0.99	0.20	0.10	0.89	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	177.94	30.92	15.76	1.52	0.76	1.18	2.02	1.43	0.67	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	55.01	12.30	6.51	0.00	0.72	0.00	0.00	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.92	7.29	6.19	0.14	0.14	0.14	0.00	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	21.49	16.12	13.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	26.67	7.21	3.17	0.72	0.43	0.29	0.00	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	89.97	23.72	15.54	0.00	1.64	0.82	0.00	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.45	8.18	3.64	0.39	0.26	0.13	0.00	0.00	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	45.87	10.98	6.26	0.97	0.42	0.56	0.00	0.00	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	33.62	9.56	6.47	0.98	0.98	0.28	0.00	0.00	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	72.53	22.41	17.13	0.85	0.42	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	24.21	8.24	5.47	0.30	0.07	0.30	0.00	0.00	0.07	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	117.88	25.92	16.97	1.23	1.85	3.39	0.31	1.54	1.23	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	123.84	24.01	19.12	0.89	2.22	0.89	2.22	4.67	0.00	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	63.49	12.34	12.34	0.59	0.59	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.01	4.64	3.76	0.00	0.22	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.59	3.94	3.94	0.39	0.00	0.39	0.00	0.39	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	61.81	18.54	6.95	0.00	0.00	0.00	0.77	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	41.03	16.01	10.01	0.00	0.00	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	37.13	11.71	5.99	0.27	0.13	0.13	0.13	0.27	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	56.52	13.96	11.75	0.89	0.89	1.99	0.89	2.88	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	85.91	20.23	13.19	0.13	0.38	1.92	0.26	1.79	0.00	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	119.17	82.37	26.05	3.26	0.33	0.00	0.33	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	225.63	64.09	35.14	2.36	0.89	0.89	3.25	3.54	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	190.34	30.18	26.19	1.14	1.71	1.28	0.28	1.00	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	35.63	3.74	3.25	0.00	0.00	0.33	0.16	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	170.48	46.58	27.09	1.22	3.35	3.65	0.00	0.00	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.66	9.09	3.28	0.00	0.00	0.25	0.25	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	12.24	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.21	5.25	4.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	271.50	23.45	23.60	4.13	1.33	1.77	1.03	1.33	1.77	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	188.55	22.17	23.03	1.94	3.23	2.80	0.43	0.22	0.86	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	196.90	23.93	22.67	1.05	1.89	1.26	0.63	0.31	0.73	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	38.05	4.49	4.80	0.00	0.00	0.00	0.31	1.08	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	40.96	11.86	9.70	0.00	0.00	0.00	0.00	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	39.75	8.07	10.46	0.30	0.30	0.30	0.00	0.00	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	40.97	4.44	3.07	0.00	0.34	0.34	0.34	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	305.64	34.40	28.19	2.51	2.51	1.65	8.87	2.28	0.94	0.94
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	76.19	17.41	6.24	1.31	0.60	0.70	2.21	2.21	0.30	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	37.09	9.78	5.69	0.68	0.00	0.00	0.68	0.68	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.13	6.04	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	105.71	13.51	15.90	1.32	0.53	1.32	0.26	0.53	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	118.25	30.76	23.97	1.33	1.07	0.93	1.60	1.07	0.27	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	140.62	25.80	16.53	1.88	3.38	4.63	1.13	2.50	0.88	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	88.78	31.96	14.46	0.25	0.51	0.51	1.01	0.76	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	77.50	18.70	10.70	0.90	0.15	0.00	0.30	1.81	0.30	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	9.75	3.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	38.77	2.58	3.88	1.29	0.00	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	23.72	6.98	5.58	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.33	11.11	2.02	0.50	1.01	1.01	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.52	8.78	5.01	0.31	0.31	0.31	0.31	0.63	0.00	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	18.88	2.95	1.77	0.00	0.00	0.59	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	179.61	30.82	23.24	1.92	0.33	0.17	0.83	0.25	0.08	1.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	110.25	35.50	20.56	0.47	0.93	0.00	0.47	0.00	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	52.53	9.50	6.19	0.00	0.00	0.00	0.14	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	47.42	9.43	10.96	0.25	0.76	0.51	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	21.81	7.71	4.32	0.38	0.00	0.19	0.00	0.38	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	153.30	32.14	28.09	1.12	1.12	1.40	0.84	0.56	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	271.14	32.51	46.50	2.09	0.75	1.09	0.92	2.09	0.67	1.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	15.24	4.29	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	51.62	12.48	6.36	0.49	0.24	0.49	0.24	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	146.71	37.34	22.98	1.77	0.22	0.88	0.22	1.77	0.88	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	52.66	10.53	10.83	0.59	0.59	0.59	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	260.25	44.90	23.13	2.92	1.17	3.89	1.55	0.19	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	480.25	34.38	27.77	7.14	7.14	11.37	4.76	6.88	2.64	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	185.23	45.75	20.83	7.81	7.81	9.67	4.09	2.23	0.74	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	412.52	36.29	21.20	6.47	5.75	9.34	4.31	1.08	2.52	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	280.49	25.83	14.19	1.14	1.42	3.69	1.14	1.14	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	242.62	28.75	22.45	2.76	3.94	7.48	1.18	1.58	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	256.49	37.84	18.79	5.59	5.59	7.87	2.29	3.05	2.79	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	250.77	35.14	26.36	5.59	3.19	3.59	2.00	0.00	2.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	254.15	31.77	19.65	5.02	3.34	5.02	1.25	2.51	4.60	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	245.68	34.38	28.88	5.50	1.83	1.38	2.75	1.83	1.83	0.46
Synoviocyte, donor1	11291-117A4	276.55	28.45	18.18	3.53	2.36	3.03	2.02	12.46	1.01	1.18
Synoviocyte, donor2	11368-117I9	51.96	21.12	10.90	1.51	0.67	0.84	0.84	0.34	0.67	0.00
Synoviocyte, donor3	11440-118H9	53.39	18.54	9.83	0.45	1.79	1.12	1.56	2.46	0.22	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	30.73	5.72	6.43	0.36	0.00	0.36	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	5.95	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	29.64	8.34	3.94	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	17.63	4.87	3.37	0.29	0.22	0.14	0.00	0.00	0.00	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	2.32	1.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	10.31	3.44	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	59.30	19.19	10.33	0.74	0.37	0.12	0.00	0.00	0.25	0.25
Urethra, donor2	10319-105A4	50.36	34.17	7.19	1.80	3.60	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	9.56	1.33	2.13	0.00	0.00	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	5.61	1.20	1.20	0.00	0.40	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.44	1.15	2.75	0.00	0.00	0.00	0.00	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	30.98	12.71	13.37	0.22	0.89	0.67	0.00	0.00	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	31.14	11.57	8.01	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	34.31	7.15	11.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.06	3.42	4.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	17.22	5.51	3.10	0.34	0.34	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.36	5.81	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	27.07	10.41	7.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	26.62	4.59	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.95	3.65	5.48	0.91	0.00	0.00	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	44.90	22.58	10.98	1.48	1.23	0.99	0.00	0.00	0.25	0.62
Wilms' tumor cell line:HFWT	10597-108E3	65.12	35.20	20.24	1.76	0.00	1.76	0.00	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.86	7.54	8.10	0.00	0.28	0.28	0.00	0.00	0.00	0.28
achilles tendon, donor2	10292-104G4	43.40	12.40	16.53	0.00	2.07	4.13	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.76	0.25	0.25	0.00	0.00	0.51	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	32.27	7.43	8.36	0.23	0.00	0.23	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	206.79	31.70	32.64	2.02	0.95	1.31	0.00	0.00	0.59	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	59.59	28.30	18.78	2.18	1.63	1.90	0.00	0.00	0.54	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	35.70	8.43	7.59	0.28	1.69	1.69	0.00	0.00	0.84	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.40	9.52	4.44	0.42	0.42	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	11.98	2.99	2.18	0.54	1.36	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	43.62	15.86	8.37	1.32	0.00	1.32	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	16.74	7.35	7.76	1.63	1.23	1.23	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.39	0.39	0.00	0.39	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.62	4.60	2.02	0.18	0.74	0.74	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	11.70	7.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	32.30	19.06	7.67	0.93	2.09	1.16	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.85	0.78	0.26	0.00	0.26	0.26	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	33.90	10.23	4.38	1.17	1.75	1.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.82	3.25	3.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	59.63	24.26	15.22	0.41	0.41	1.65	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	33.46	8.90	6.45	0.61	0.61	0.31	0.00	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.43	8.11	7.68	0.43	1.28	0.85	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	27.90	10.92	7.89	0.00	0.30	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	39.96	13.96	9.15	0.72	0.00	0.24	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.12	4.45	0.89	0.00	0.00	0.22	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	97.06	26.35	11.01	1.33	1.00	1.00	0.00	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	31.59	22.30	0.00	0.00	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	65.92	23.73	11.68	1.88	0.38	0.00	0.00	0.00	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	56.70	19.19	13.96	1.31	1.31	0.44	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	52.48	11.25	20.62	0.00	0.00	1.87	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	39.09	25.90	12.25	0.94	0.24	0.00	0.00	0.00	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	132.94	46.69	18.61	0.47	0.62	0.16	0.31	0.00	0.31	0.00
adipose, donor1	10184-103D4	48.67	56.30	39.29	8.21	2.93	4.10	0.00	0.00	0.59	1.17
adipose, donor2	10185-103D5	17.44	24.33	16.63	3.24	0.00	0.81	0.00	0.00	0.41	0.00
adipose, donor3	10186-103D6	27.23	41.93	16.88	4.08	0.54	1.09	0.00	0.00	0.54	0.00
adipose, donor4	10187-103D7	13.87	21.67	19.07	4.33	1.73	2.60	0.00	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.63	7.42	8.21	0.63	0.47	0.00	0.00	0.00	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	0.00	10.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	6.54	4.14	4.40	0.40	0.27	0.00	0.00	0.00	0.00	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	20.37	8.58	3.57	1.43	0.36	0.71	0.00	0.00	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	29.91	14.37	9.27	0.46	0.00	0.46	0.00	0.00	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	28.06	6.42	8.45	0.34	0.00	0.34	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	15.32	7.37	6.78	0.00	0.29	0.29	0.00	0.00	0.29	1.47
amygdala - adult, donor10196	10167-103B5	67.59	75.89	40.32	1.19	0.00	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	62.05	54.75	29.81	0.61	3.45	2.43	0.00	0.00	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	68.75	40.02	11.94	1.94	1.29	0.65	0.00	0.00	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	35.65	8.40	9.93	0.64	0.13	0.13	0.00	0.00	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	68.14	11.69	11.69	2.00	0.33	0.00	0.00	0.00	1.34	0.00
aorta, adult, pool1	10052-101G7	32.36	22.36	14.12	0.00	0.59	0.59	0.00	0.00	0.39	0.00
appendix, adult	10189-103D9	43.08	13.20	10.87	1.16	0.00	0.00	0.00	0.00	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	29.23	9.97	7.22	0.69	0.34	0.00	0.00	0.00	0.34	0.34
artery, adult	10190-103E1	10.87	8.15	8.15	1.36	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	99.38	17.96	16.23	1.01	0.72	1.16	0.14	1.01	0.58	0.43
b cell line:RPMI1788	10427-106D4	36.13	5.80	5.65	0.89	0.30	0.00	0.00	0.30	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	333.21	34.40	37.46	4.99	1.66	3.88	5.83	14.43	1.66	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	94.96	15.58	11.91	0.30	0.40	0.69	0.00	0.00	0.00	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	2.85	0.84	0.84	0.17	0.00	0.00	0.00	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.37	9.51	6.15	0.00	0.56	0.56	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	38.89	19.77	10.43	0.00	0.22	0.00	0.22	0.76	0.00	0.22
blood, adult, pool1	10053-101G8	4.43	6.64	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	134.45	41.96	29.12	1.71	0.00	0.00	5.14	0.86	0.00	0.86
bone marrow, adult	10192-103E3	163.31	43.86	18.90	4.05	4.72	6.07	0.00	0.00	0.67	0.67
brain, adult, donor1	10084-102B3	26.65	20.50	10.25	1.03	1.03	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	43.65	50.67	24.05	0.45	0.89	0.56	0.00	0.00	0.00	0.00
brain, fetal, pool1	10085-102B4	82.81	56.10	13.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	47.57	19.49	9.58	1.32	0.99	0.33	0.00	0.00	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.83	17.60	9.86	0.50	0.00	0.12	0.00	0.00	0.12	0.25
breast, adult, donor1	10080-102A8	74.50	26.52	14.52	0.00	0.63	0.00	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	21.60	11.05	4.83	0.25	0.25	1.14	0.00	0.00	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	28.76	12.06	7.11	1.24	0.31	0.62	0.00	0.00	0.00	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.71	7.37	8.29	1.38	0.92	0.46	0.00	0.00	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.17	7.50	3.87	0.48	0.48	1.45	0.00	0.00	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	21.16	11.75	11.75	1.41	0.47	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	36.97	6.78	6.23	0.66	0.22	0.44	0.00	0.00	0.22	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	13.31	10.77	8.87	0.63	0.95	0.32	0.00	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	58.56	33.27	18.37	1.60	1.60	2.13	0.27	0.00	1.33	1.06
caudate nucleus - adult, donor10196	10177-103C6	62.17	67.93	39.14	1.15	3.45	0.00	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	68.77	65.26	31.96	1.00	3.51	1.00	0.00	0.00	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	65.72	64.19	25.22	0.00	6.11	2.29	0.00	0.00	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	93.39	35.52	8.79	1.10	0.37	0.37	0.00	0.00	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	34.96	104.88	29.13	2.91	2.91	5.83	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	37.15	83.06	24.55	1.71	2.35	2.14	0.00	0.00	0.00	0.21
cerebellum, adult, pool1	10083-102B2	13.11	37.25	14.14	0.69	1.03	1.03	0.00	0.00	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	44.84	77.22	5.81	0.83	1.66	0.83	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	54.21	51.18	26.98	1.01	1.26	1.26	0.00	0.00	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	14.62	11.69	7.31	0.00	0.00	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	4.89	11.07	4.46	0.43	0.14	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	9.11	7.46	2.98	0.33	0.00	0.00	0.00	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	47.25	26.67	11.34	0.63	0.52	0.31	0.42	0.00	0.00	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	47.24	10.59	4.18	0.84	0.28	0.28	0.28	0.28	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	77.07	32.66	18.29	1.31	0.00	0.00	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	169.26	14.54	13.17	1.86	1.62	1.62	0.00	0.00	0.50	0.12
choriocarcinoma cell line:SCH	10785-110H2	111.75	3.33	5.30	1.85	0.99	1.36	0.00	0.00	0.12	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	146.34	15.89	17.08	3.08	0.71	0.47	0.00	0.00	0.00	1.19
chorionic membrane cells, donor1	12238-129G6	51.00	8.83	6.84	1.42	0.00	0.00	0.00	0.00	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	309.73	19.09	27.64	1.89	1.09	1.29	0.99	0.20	0.50	0.70
chorionic membrane cells, donor3	12240-129G8	41.76	9.34	13.74	1.10	0.55	1.65	0.00	0.00	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	18.18	7.07	3.03	0.00	3.03	2.02	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	27.28	11.53	5.38	0.96	0.58	0.58	0.00	0.00	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	44.14	18.37	8.87	1.06	0.84	0.63	0.00	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.63	14.89	12.33	0.26	0.26	0.77	0.00	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	24.67	17.90	11.13	0.73	0.24	0.00	0.00	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	34.21	17.31	10.38	0.61	0.81	0.41	0.00	0.00	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	43.28	28.86	10.01	2.06	1.18	1.18	0.00	0.00	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	101.64	32.32	20.33	1.04	0.52	1.04	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	16.92	11.43	7.54	1.37	1.37	0.91	0.00	0.00	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	38.52	14.05	9.89	0.69	0.35	0.17	0.00	0.00	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	73.03	9.70	9.70	0.55	0.18	0.73	0.00	0.00	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	77.54	27.37	36.49	0.00	0.76	0.38	0.00	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	41.65	16.66	11.90	0.00	0.00	0.00	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	41.95	15.16	8.23	0.47	0.12	0.12	0.12	0.00	0.00	0.35
colon, fetal, donor1	10070-101I7	29.05	12.98	11.74	2.47	1.24	0.00	0.00	0.00	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	183.34	13.75	13.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	76.06	18.27	10.20	1.70	0.00	0.42	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	58.26	16.15	5.89	1.21	0.30	0.45	0.00	0.00	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	65.99	16.64	6.06	1.83	0.56	0.56	0.00	0.00	0.28	0.71
corpus callosum, adult, pool1	10042-101F6	31.40	31.18	17.47	0.33	0.22	0.33	0.11	0.00	0.22	0.00
cruciate ligament, donor2	10295-104G7	60.79	12.97	2.43	2.43	1.62	0.81	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	52.97	28.89	14.45	0.80	0.80	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	32.64	29.76	21.12	0.96	1.20	0.96	0.00	0.00	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.81	5.51	3.67	0.46	0.46	1.15	0.00	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	12.05	5.64	3.59	0.26	0.00	0.26	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	37.31	6.98	6.02	1.44	0.72	0.24	0.00	0.00	0.00	0.72
ductus deferens, adult	10196-103E7	23.42	16.45	8.47	0.00	1.00	0.50	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	15.84	7.20	0.00	0.00	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.23	19.86	10.30	1.47	2.21	0.00	0.00	0.00	0.00	2.21
dura mater, adult, donor1	10041-101F5	72.59	48.64	18.58	0.25	0.66	0.08	0.91	0.00	0.41	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	42.86	5.77	2.44	0.67	0.22	0.89	0.00	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	33.67	19.06	7.31	0.43	0.14	0.00	0.00	0.00	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	14.80	7.40	3.70	1.23	0.00	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	11.81	7.87	6.66	0.61	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	21.30	10.19	7.72	0.31	0.31	0.31	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	22.33	10.51	15.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	23.13	21.79	7.71	1.01	0.34	0.34	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	42.77	31.53	17.40	2.72	1.45	1.45	0.00	0.00	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	50.82	32.16	8.84	1.13	2.25	2.25	0.00	0.00	0.16	0.32
epidermoid carcinoma cell line:A431	10426-106D3	28.01	7.56	8.11	1.11	0.22	0.11	0.00	0.00	0.00	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	52.68	12.21	12.32	0.33	0.55	0.44	0.00	0.00	0.11	0.00
epididymis, adult	10197-103E8	42.07	20.51	8.79	1.67	0.63	1.67	0.00	0.00	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	54.64	9.93	6.92	1.95	1.24	0.53	0.00	0.00	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.98	7.86	3.54	0.39	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1.31	0.92	0.79	0.13	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.89	1.08	0.49	0.10	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1.23	2.02	0.45	0.00	0.11	0.22	0.00	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	23.78	12.64	6.58	0.32	0.21	0.00	0.21	0.00	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	38.45	34.57	12.77	0.38	0.38	0.38	0.00	0.00	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	53.12	33.80	2.41	2.41	0.00	0.00	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	8.42	10.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	35.72	11.91	17.86	0.00	1.49	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	45.86	14.90	11.46	1.15	1.15	1.15	0.00	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	8.74	10.20	13.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	38.90	29.75	13.98	0.51	1.02	1.27	0.00	0.00	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	80.01	18.21	16.16	0.90	0.90	1.15	0.64	0.00	0.51	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	45.82	10.45	7.36	2.61	0.71	0.00	0.00	0.00	0.00	0.95
frontal lobe, adult, pool1	10040-101F4	84.82	65.11	35.47	0.38	0.66	0.56	0.00	0.00	0.47	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	23.12	4.20	6.31	1.50	0.60	1.20	0.00	0.00	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	15.27	9.60	9.05	0.18	0.18	0.18	0.00	0.00	0.09	0.18
gall bladder, adult	10198-103E9	36.46	14.73	8.45	0.97	0.24	0.00	0.24	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	13.42	3.22	4.83	0.54	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	22.04	6.35	4.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	59.14	14.57	8.66	0.84	2.32	1.48	0.21	0.00	1.06	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	13.54	11.80	5.03	0.39	0.19	0.00	0.00	0.00	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	62.63	28.36	20.66	0.82	0.98	0.66	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	9.15	5.49	1.83	0.92	0.00	0.92	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	91.15	19.42	15.54	2.06	2.74	1.83	0.00	0.00	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	4.02	2.98	1.15	0.46	0.11	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	22.11	4.76	4.90	0.14	0.00	0.70	0.00	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.72	6.48	3.74	0.50	0.00	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	63.96	24.59	11.61	1.27	1.27	0.32	1.06	0.84	0.11	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	63.62	26.82	13.48	1.69	0.14	0.98	1.69	0.70	0.14	0.70
glioblastoma cell line:T98G	10485-107A8	31.90	16.67	7.95	0.33	0.22	0.55	0.00	0.11	0.11	0.33
glioma cell line:GI-1	10413-106B8	29.29	15.23	7.61	0.00	0.59	0.29	0.00	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	42.28	52.48	21.14	0.00	0.73	2.19	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	50.53	37.59	23.92	1.95	1.46	1.46	0.00	0.00	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	61.61	32.86	16.43	1.37	1.37	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	50.09	17.59	6.93	0.00	0.53	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	166.41	26.92	19.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	112.96	31.68	16.64	1.60	1.92	1.60	0.00	0.32	0.00	1.28
hIPS +CCl2, biol_rep1	14383-156B9	36.27	17.45	11.94	0.00	0.46	1.84	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	26.98	13.72	15.55	0.46	0.46	0.91	0.00	0.00	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	26.41	17.39	11.59	0.00	0.00	1.29	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	23.00	24.43	10.06	1.44	1.44	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	24.69	19.20	12.35	1.37	1.37	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	49.66	37.52	17.66	1.10	1.10	1.10	0.00	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	5.46	1.72	1.44	0.00	0.29	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	49.93	22.12	13.75	1.49	1.20	0.90	0.30	0.30	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	45.76	24.06	10.98	1.05	1.31	0.78	0.00	0.00	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	65.78	18.32	14.15	3.33	0.83	0.83	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	21.43	7.55	5.71	1.02	0.20	0.82	0.00	0.00	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	17.88	5.11	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	25.53	7.36	6.90	0.23	0.00	0.00	0.00	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	48.46	22.49	10.37	0.41	0.21	0.21	0.21	0.00	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	235.10	28.69	32.70	2.16	1.85	0.62	1.23	3.70	0.31	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	32.11	7.14	16.65	2.38	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	50.72	14.47	11.05	0.88	0.66	0.66	0.00	0.00	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	53.53	15.17	11.77	0.61	0.36	0.61	0.00	0.00	0.12	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	54.27	14.65	10.21	1.11	1.11	0.71	0.00	0.00	0.20	0.30
hepatoma cell line:Li-7	10484-107A7	14.46	7.79	4.89	0.33	0.00	0.44	0.00	0.00	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	39.30	8.24	6.13	0.50	0.70	0.60	0.00	0.00	0.50	0.30
hippocampus - adult, donor10196	10169-103B7	35.01	46.37	21.77	2.84	2.84	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	54.09	53.47	30.41	2.04	2.45	2.04	0.00	0.00	0.82	0.20
hippocampus, adult, donor10258	10374-105G5	81.66	73.20	43.32	1.00	2.49	3.49	0.00	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	35.95	25.38	9.52	0.70	1.41	0.35	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	24.41	26.24	17.09	3.66	3.66	1.83	0.00	0.00	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.26	15.71	8.64	0.98	0.59	0.59	0.00	0.00	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	20.06	15.74	7.62	2.54	0.76	0.51	0.00	0.00	0.76	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	24.25	23.12	12.41	2.82	0.56	1.13	0.00	0.00	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	23.24	26.60	19.88	5.94	5.16	3.61	0.00	0.00	4.13	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	36.06	33.41	14.80	2.66	0.76	1.52	0.00	0.00	1.52	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	40.29	36.20	19.27	5.26	1.75	3.21	0.00	0.00	0.58	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.53	36.62	21.54	4.09	1.29	1.08	0.00	0.00	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	40.04	42.54	10.84	3.75	0.83	0.42	0.00	0.00	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	63.93	54.23	22.73	2.13	0.00	0.71	0.00	0.00	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.70	54.32	15.91	2.73	1.45	3.38	0.00	0.00	0.80	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	77.43	53.19	22.89	2.02	0.00	0.00	0.00	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	13.93	13.61	5.63	0.94	1.41	0.94	0.00	0.00	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	9.33	12.28	8.35	1.97	2.95	4.91	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	16.58	4.36	3.49	0.87	2.62	0.00	0.00	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	29.02	38.18	20.62	3.05	1.53	1.15	0.00	0.00	0.76	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	28.34	39.25	21.80	1.31	0.87	1.31	0.00	0.00	0.00	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.49	46.98	19.49	4.00	2.50	1.00	0.00	0.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.96	35.61	21.10	4.14	1.32	0.38	0.00	0.00	0.75	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.83	52.29	22.28	2.73	0.45	0.45	0.00	0.00	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.91	36.96	12.53	4.70	0.94	0.63	0.00	0.00	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	31.19	58.46	16.98	4.08	1.14	0.98	0.00	0.00	1.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.42	57.77	13.64	3.19	2.03	1.45	0.00	0.00	0.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.66	60.38	10.46	5.38	1.49	0.60	0.00	0.00	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.70	15.33	9.61	2.40	0.92	0.74	0.00	0.00	0.74	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	15.98	18.54	9.70	1.71	0.86	0.57	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	23.27	22.87	13.88	2.04	0.82	1.63	0.00	0.00	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.56	38.73	15.49	2.46	2.11	2.11	0.00	0.00	2.82	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	27.24	27.24	15.84	1.90	1.58	0.32	0.00	0.00	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.35	27.24	10.89	2.42	0.91	1.21	0.00	0.00	0.30	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.13	38.27	21.20	2.07	0.52	0.00	0.00	0.00	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.23	37.86	13.28	4.65	0.66	0.00	0.00	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.57	39.76	10.00	1.80	0.77	1.54	0.00	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	56.75	58.80	18.15	2.05	1.28	4.60	0.26	0.00	2.05	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	40.89	66.64	18.93	3.79	0.76	0.00	0.00	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	69.90	65.53	15.12	6.05	1.68	1.01	0.00	0.00	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.28	15.94	9.18	1.69	0.48	0.00	0.00	0.00	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.50	14.71	4.46	4.90	1.34	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.49	19.51	9.76	3.41	0.98	0.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	35.15	39.12	23.84	7.03	1.83	0.92	0.00	0.00	1.53	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	91.09	156.16	94.34	32.53	19.52	9.76	0.00	0.00	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	43.68	40.71	21.51	5.63	2.65	0.99	0.00	0.00	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.82	51.99	24.08	1.64	1.09	0.55	0.00	0.00	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.25	41.62	14.11	2.53	0.72	0.36	0.00	0.00	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	31.67	40.21	16.73	1.42	0.71	1.78	0.00	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	45.35	87.12	10.74	3.58	1.19	4.77	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	82.34	115.52	33.04	6.23	1.63	0.81	0.00	0.00	0.54	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	42.03	68.97	12.12	4.58	1.08	0.81	0.00	0.00	1.08	0.54
immature langerhans cells, donor1	11904-125F5	115.26	10.17	8.96	0.73	0.73	0.24	0.00	0.00	0.00	0.24
immature langerhans cells, donor2	11905-125F6	27.72	3.17	5.54	0.00	0.00	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	93.40	74.48	34.26	0.19	0.47	0.57	0.00	0.00	0.00	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	2.60	1.95	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	90.72	27.13	12.82	1.20	0.60	0.90	0.00	0.00	0.50	0.00
kidney, fetal, pool1	10045-101F9	107.66	23.63	18.67	0.42	0.57	0.00	0.07	0.07	0.07	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	48.71	20.17	13.21	0.00	0.43	0.43	0.14	0.00	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.47	5.25	4.56	0.14	0.28	0.14	0.00	0.00	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.54	5.50	5.32	0.37	0.18	0.18	0.00	0.00	0.00	0.18
left atrium, adult, donor1	10079-102A7	29.42	6.54	10.35	1.09	1.09	0.54	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	14.66	4.55	4.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	22.16	9.30	5.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	28.02	8.62	2.51	0.36	0.00	1.08	0.00	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	50.54	11.41	3.80	0.54	2.17	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	37.88	14.33	6.80	1.46	1.46	1.21	0.00	0.00	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	266.67	44.45	25.40	0.00	0.00	0.00	12.70	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	18.82	13.59	0.00	0.00	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	50.53	16.29	11.81	0.59	0.83	0.94	0.00	0.00	0.00	0.35
liposarcoma cell line:KMLS-1	10782-110G8	102.32	28.74	16.25	1.09	0.62	0.62	1.25	0.47	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	31.19	10.23	12.18	0.24	0.12	0.37	0.00	0.00	0.12	0.37
liver, adult, pool1	10018-101C9	29.82	13.78	6.00	0.00	0.16	0.32	0.00	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	15.99	5.64	7.53	1.88	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	27.42	23.19	10.21	1.75	0.44	0.29	0.00	0.00	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	27.50	19.93	12.92	1.29	1.29	0.55	0.00	0.00	0.74	0.00
locus coeruleus, adult, donor10258	10375-105G6	30.75	16.93	8.75	0.28	1.41	1.41	0.00	0.00	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	31.97	26.92	11.78	1.68	1.68	0.42	0.42	0.00	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	8.58	4.98	4.01	0.14	0.14	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	8.96	12.41	6.20	0.69	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	53.52	13.45	16.74	0.13	0.53	0.53	0.00	0.00	0.40	0.53
lung, adult, pool1	10019-101D1	55.05	16.30	7.68	0.24	0.12	0.00	0.12	0.24	0.24	0.12
lung, fetal, donor1	10068-101I5	154.98	59.36	27.40	0.00	0.86	0.57	0.00	0.00	0.86	0.57
lung, right lower lobe, adult, donor1	10075-102A3	56.36	11.46	7.79	2.29	1.83	1.37	0.00	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	13.73	8.05	1.89	0.00	0.47	1.42	0.00	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	9.42	4.60	5.70	0.00	0.22	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	9.06	5.89	4.23	0.15	0.30	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	73.91	11.04	5.10	0.00	0.85	0.85	0.00	0.00	0.85	2.55
mature adipocyte, donor1	12231-129F8	314.79	92.79	47.95	3.11	0.44	0.00	0.00	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	318.35	73.05	44.62	3.11	0.42	0.21	0.00	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	358.20	102.65	45.99	1.90	1.19	0.00	0.00	0.00	0.47	0.71
mature adipocyte, donor4	12234-129G2	307.96	109.24	40.54	2.90	0.00	0.53	0.00	0.00	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	6.19	9.77	4.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	62.04	76.71	42.87	3.38	2.26	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	65.10	61.24	32.74	1.47	2.21	1.84	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	60.36	55.60	26.05	2.22	1.27	1.27	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	104.06	72.50	22.60	0.00	4.26	2.13	0.43	0.00	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	62.27	72.23	28.86	1.52	7.26	6.08	0.00	0.00	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	61.12	62.39	28.65	1.27	1.06	0.85	0.00	0.00	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	127.13	100.17	46.23	0.00	5.78	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	330.13	129.18	0.00	43.06	57.41	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	116.29	50.61	18.66	2.51	1.08	0.72	0.00	0.00	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	24.01	25.96	12.98	1.95	1.30	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	21.05	26.47	13.62	0.00	0.93	0.93	0.00	0.00	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	26.28	26.20	16.16	0.16	0.49	0.24	0.00	0.00	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	20.14	16.32	7.99	0.69	0.35	0.35	0.00	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	26.57	11.51	13.73	0.44	1.55	0.22	0.00	0.00	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	21.40	9.17	7.46	0.00	0.00	0.00	0.00	0.00	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	51.17	20.84	13.66	0.57	0.14	0.72	0.00	0.00	0.14	0.29
melanoma cell line:G-361	10465-106H6	29.59	28.78	16.56	3.26	1.90	0.81	0.00	0.00	1.09	0.27
meningioma cell line:HKBMM	10691-109F7	33.29	18.45	9.59	0.90	1.27	1.09	0.00	0.00	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	33.48	22.03	10.57	3.52	0.88	0.88	0.00	0.00	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	62.99	40.70	20.22	1.30	0.52	1.04	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	48.95	17.34	9.21	0.46	0.92	1.53	1.07	0.46	0.46	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	152.70	27.63	20.54	1.45	1.82	2.36	2.18	4.73	0.36	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	40.17	25.67	7.87	0.41	0.83	2.90	0.41	0.00	0.41	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	39.33	31.19	13.35	0.42	0.84	0.42	0.28	0.14	0.84	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	59.31	25.61	13.48	0.39	0.77	0.77	1.73	0.77	0.19	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	68.02	34.01	6.25	0.00	0.00	0.69	1.39	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	69.34	14.07	12.19	0.17	0.69	1.03	1.89	2.57	0.00	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	54.17	22.89	11.73	0.58	0.46	0.58	0.23	0.23	0.35	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	38.07	14.99	9.28	0.13	0.66	0.66	0.40	1.33	0.27	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	57.53	24.04	11.07	0.68	0.95	1.08	0.54	0.68	0.54	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	150.66	22.48	21.91	0.71	2.28	1.99	0.43	0.57	0.85	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	52.37	10.21	4.61	0.66	0.33	0.66	2.31	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	121.35	20.20	15.22	0.69	0.69	0.83	0.42	0.69	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	87.97	18.15	10.47	1.40	1.40	2.09	1.05	1.75	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	103.72	25.52	19.40	1.63	1.43	1.43	0.00	1.63	0.61	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	175.05	13.66	14.02	2.52	2.88	2.52	2.16	0.00	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	47.69	13.24	8.48	0.93	0.62	0.62	0.00	0.00	0.10	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	78.89	11.17	6.61	1.60	1.37	2.96	0.23	0.00	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	149.78	26.43	22.66	0.00	2.52	2.10	0.00	0.84	1.68	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	103.41	20.47	16.59	0.75	0.45	1.49	0.45	0.30	0.15	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	54.27	15.49	10.07	0.44	0.26	0.88	0.09	0.96	0.18	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	79.15	18.04	13.62	1.47	1.47	0.37	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	190.87	17.74	14.88	1.72	4.01	5.44	1.14	1.14	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	234.08	35.37	20.63	4.63	4.21	7.58	1.68	0.00	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	179.47	20.55	17.81	1.83	3.20	1.83	0.00	0.00	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	195.16	22.25	20.72	2.30	2.05	1.53	1.79	2.30	0.26	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	222.49	25.65	20.68	2.36	1.31	1.57	1.83	2.09	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	230.45	26.50	17.56	1.85	2.16	0.92	0.62	2.77	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	186.64	27.30	16.71	4.47	2.35	3.06	1.65	1.18	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	216.27	24.03	19.29	3.05	1.35	1.35	1.35	2.37	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	181.95	31.83	16.11	2.75	1.57	2.75	1.18	1.96	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	176.55	19.93	19.46	1.39	2.32	2.78	2.32	2.78	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	227.56	26.53	19.04	2.31	1.73	1.73	2.02	1.44	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	201.01	32.13	21.64	2.01	0.45	2.01	2.23	1.12	0.89	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	212.95	27.16	18.27	2.64	0.24	0.96	2.64	1.20	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	316.80	27.87	24.93	3.67	1.47	1.47	1.47	2.20	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	176.56	21.48	15.44	2.35	2.01	2.01	0.34	2.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	189.13	31.93	21.70	2.46	4.09	2.46	1.23	2.46	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	237.98	27.06	16.75	1.29	1.72	1.72	0.00	0.86	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	292.58	21.88	16.41	5.47	8.20	2.73	0.00	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	289.24	36.15	30.99	5.16	10.33	0.00	0.00	0.00	10.33	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	261.13	27.61	21.44	3.90	2.27	1.95	0.65	0.97	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	213.88	34.92	21.82	8.73	5.82	8.73	2.91	4.36	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	280.93	29.85	22.92	4.26	2.13	3.73	0.00	2.13	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	248.60	27.80	10.63	7.36	1.64	2.45	1.64	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	261.22	26.82	20.21	7.39	5.44	3.89	2.33	1.17	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	224.56	10.49	14.69	10.49	10.49	6.30	0.00	0.00	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	219.56	26.82	17.88	6.95	1.99	6.95	0.99	3.97	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	152.55	57.21	23.84	4.77	14.30	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	246.67	39.14	24.31	6.52	2.37	3.56	0.59	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	255.88	34.12	20.71	3.66	2.44	3.66	0.00	2.44	2.44	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	351.68	0.00	0.00	0.00	27.05	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	259.69	30.40	18.37	5.07	2.53	1.90	1.27	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	273.16	30.01	16.21	4.48	3.10	2.76	0.34	0.69	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	285.84	23.64	15.04	4.30	4.30	2.15	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	155.68	23.95	11.98	7.98	3.99	3.99	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	210.08	20.66	6.89	3.44	10.33	3.44	0.00	0.00	3.44	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	158.91	19.15	12.22	2.85	2.85	2.04	0.41	0.00	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	173.98	28.60	25.42	3.18	3.18	1.59	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	93.15	25.35	18.28	3.54	4.13	2.36	0.00	0.00	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	106.60	26.18	14.03	2.18	1.87	0.62	0.00	0.00	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	97.58	25.40	26.73	4.01	0.00	2.67	0.00	0.00	4.01	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	79.24	31.93	16.56	1.18	1.18	1.18	0.00	0.00	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	102.72	35.95	28.25	7.70	10.27	10.27	2.57	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	116.34	33.04	22.03	1.38	6.20	2.75	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	181.59	26.22	20.78	3.96	7.92	2.97	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	182.81	13.46	16.82	2.24	3.36	11.22	1.12	1.12	3.36	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	167.92	22.26	18.45	5.09	3.82	4.45	0.00	0.64	1.91	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	186.18	12.09	11.69	3.22	1.21	2.42	0.00	0.40	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	139.56	15.26	19.63	13.08	2.18	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	91.23	7.60	5.07	1.27	0.00	2.53	0.00	0.00	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	115.31	11.53	12.74	1.82	0.61	1.82	0.61	2.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	162.68	22.59	31.63	9.04	9.04	4.52	4.52	0.00	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	117.79	13.18	12.36	2.47	6.59	5.77	1.65	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	161.92	28.18	16.27	2.38	0.60	0.40	4.17	0.99	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	108.71	23.36	13.95	1.30	1.95	3.57	2.27	1.30	1.30	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	114.09	26.48	10.19	4.07	4.07	5.09	2.04	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	369.06	47.97	49.52	1.55	0.00	0.00	8.51	4.64	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	36.62	7.80	10.16	2.36	0.24	0.00	0.00	0.00	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	62.78	20.85	7.88	1.85	0.23	0.46	0.00	0.00	0.23	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	12.82	0.00	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	32.88	9.56	4.42	0.21	0.31	0.31	0.00	0.00	1.13	0.00
mesothelioma cell line:Mero-25	10850-111F4	11.12	1.59	0.91	0.23	0.23	0.23	0.00	0.00	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	25.91	15.89	5.87	0.98	0.98	0.49	0.00	0.00	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	46.72	24.14	8.86	0.44	0.22	0.66	0.00	0.22	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	42.31	12.61	11.04	0.79	1.84	1.05	0.53	0.00	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	48.68	18.38	8.34	0.17	1.70	1.53	0.17	0.00	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	24.52	5.56	2.27	0.51	0.00	1.01	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	26.50	10.35	5.80	0.62	0.62	1.04	0.00	0.00	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	137.49	20.04	7.95	1.66	2.82	1.82	0.00	0.00	1.16	0.17
mesothelioma cell line:NCI-H226	10846-111E9	30.41	9.05	5.97	0.54	0.54	0.90	0.00	0.00	0.36	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	10.76	9.05	3.42	0.34	0.00	0.68	0.00	0.00	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	7.13	4.07	2.04	0.51	0.00	0.51	0.00	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	35.88	8.81	6.52	0.98	0.33	1.30	0.33	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	14.09	8.40	4.88	0.27	0.00	0.81	0.00	0.00	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	33.78	12.28	6.33	0.77	0.58	0.38	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	32.36	10.62	4.15	0.12	0.12	0.37	0.00	0.00	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	47.02	14.72	7.00	0.54	0.18	0.18	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.67	12.41	12.73	3.92	2.61	2.29	0.33	0.00	0.00	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.11	7.21	5.72	0.21	0.42	0.00	0.00	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	38.47	14.97	10.14	0.00	0.00	0.00	0.00	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.64	6.28	4.57	0.38	0.57	0.00	0.00	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	74.84	19.59	17.56	0.00	1.48	1.29	0.00	0.00	0.37	0.55
myeloma cell line:PCM6	10474-106I6	9.49	4.94	1.98	0.40	0.59	0.79	0.00	0.00	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	108.56	27.90	21.31	0.51	0.51	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	28.24	38.05	17.06	0.20	0.98	1.37	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.47	5.01	3.79	0.33	0.22	0.22	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.18	5.00	3.53	0.44	0.00	0.00	0.00	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	15.46	6.62	9.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	59.13	48.77	30.37	1.15	0.69	0.92	0.00	0.00	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	168.94	110.57	72.78	2.99	1.12	0.94	0.00	0.00	0.56	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	17.71	65.16	20.03	0.00	1.48	1.69	0.00	0.00	0.21	0.63
neuroblastoma cell line:NH-12	10555-107I6	31.49	62.61	30.38	2.05	1.49	1.68	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	24.20	26.81	9.25	0.71	0.95	0.47	0.24	0.00	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	9.03	16.00	4.28	0.63	0.63	0.79	0.00	0.00	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	19.32	22.54	10.26	1.01	0.60	1.21	0.00	0.00	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.09	12.72	7.63	0.00	0.00	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	347.08	42.32	29.81	5.32	1.06	0.53	1.60	9.05	0.27	2.40
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	95.55	24.52	35.18	1.18	0.85	0.34	0.00	0.00	0.51	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.81	8.01	12.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	216.73	21.48	26.93	4.17	1.92	2.56	2.56	1.60	1.28	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	136.90	21.28	19.44	3.15	3.15	3.15	2.89	1.58	1.05	1.05
nucleus accumbens, adult, pool1	10037-101F1	79.49	66.09	34.21	0.28	0.47	0.37	0.00	0.09	0.19	0.09
occipital cortex - adult, donor10196	10172-103C1	67.99	94.78	24.72	6.18	0.00	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	62.53	59.31	24.96	2.42	3.22	4.03	0.00	0.00	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	119.01	66.60	17.47	1.46	0.73	0.36	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	50.12	42.77	21.78	2.36	1.05	1.05	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	187.52	98.69	43.77	3.86	3.00	6.01	0.00	0.43	0.00	0.43
occipital pole, adult, pool1	10036-101E9	36.74	27.28	14.43	0.08	0.24	0.08	0.00	0.00	0.00	0.16
olfactory region, adult	10195-103E6	54.26	62.28	31.33	1.53	3.44	2.48	0.00	0.00	0.00	0.19
optic nerve, donor1	10277-104E7	28.01	22.01	6.00	2.00	2.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	11.05	11.05	2.96	0.00	0.11	0.11	0.00	0.00	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	19.23	10.17	10.72	0.27	0.14	0.14	0.00	0.00	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.58	6.77	4.91	0.34	0.51	1.02	0.00	0.00	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.28	8.09	5.20	0.23	0.58	0.35	0.00	0.00	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	333.95	25.58	27.93	3.23	0.88	1.76	10.58	3.53	0.00	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	59.80	42.05	22.42	0.00	0.00	0.00	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	76.34	22.69	10.60	0.42	1.06	0.64	0.00	0.00	0.21	0.21
ovary, adult, pool1	10020-101D2	29.35	18.52	8.56	0.17	0.35	0.17	0.00	0.00	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	73.33	19.98	21.63	1.28	0.73	1.28	0.00	0.18	0.73	1.10
pancreas, adult, donor1	10049-101G4	16.93	19.75	8.47	0.00	0.94	1.88	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	179.18	9.78	9.78	1.96	2.80	1.12	0.00	0.00	0.56	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	33.22	9.54	8.52	0.34	3.41	2.04	0.00	0.00	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	32.29	12.42	9.27	0.17	0.17	0.00	0.00	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	62.88	52.90	28.10	0.46	0.18	0.37	0.00	0.00	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	51.38	52.85	24.96	1.47	0.73	3.67	0.00	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	47.02	60.19	27.27	0.94	1.88	1.88	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	60.14	60.14	22.23	0.57	1.71	1.71	0.00	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	55.25	48.20	27.23	0.18	0.35	0.53	0.00	0.00	0.26	0.18
parietal lobe, fetal, donor1	10072-101I9	179.42	112.50	42.67	3.88	4.85	4.85	0.00	0.00	4.85	0.97
parietal lobe, newborn, donor10223	10356-105E5	103.19	52.71	10.84	1.50	0.37	0.75	0.00	0.00	0.00	0.00
parotid gland, adult	10199-103F1	9.25	5.55	2.47	0.62	0.00	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	24.17	18.80	4.30	1.61	0.54	0.54	0.00	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	29.01	14.69	8.74	0.37	0.56	0.93	0.00	0.00	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.88	3.64	3.35	0.15	0.15	0.29	0.00	0.00	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	36.12	49.02	22.58	2.58	1.94	0.00	0.00	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	29.02	52.71	33.76	2.37	0.59	1.78	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	28.22	33.86	15.05	1.25	0.63	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	33.39	15.18	12.14	0.00	0.00	2.02	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	25.02	22.41	13.55	0.52	0.00	1.56	0.00	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	13.62	12.77	4.26	0.00	0.85	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	120.83	22.25	17.09	0.54	1.08	0.00	0.11	0.00	0.32	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	48.87	14.57	10.46	0.93	0.66	1.46	0.00	0.00	0.26	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	10.74	12.45	7.63	0.16	0.00	0.00	0.00	0.00	0.00	0.16
pons, adult, pool1	10033-101E6	31.24	39.33	17.64	0.43	0.43	0.17	0.00	0.00	0.00	0.26
postcentral gyrus, adult, pool1	10032-101E5	46.64	37.31	17.70	0.09	0.35	0.52	0.00	0.00	0.26	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	64.83	8.37	14.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	25.20	6.99	7.57	0.58	0.00	1.02	0.00	0.00	0.15	0.29
prostate cancer cell line:PC-3	10439-106E7	31.58	16.52	11.62	1.09	0.18	0.36	0.00	0.00	0.00	0.73
prostate, adult, pool1	10022-101D4	36.91	24.49	10.52	0.45	0.18	0.27	0.00	0.00	0.00	0.09
putamen, adult, donor10196	10176-103C5	60.90	79.32	39.42	1.18	2.60	2.36	0.00	0.00	0.24	0.24
putamen, adult, donor10252	10152-102I8	58.82	41.18	27.45	0.00	1.96	3.92	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	67.75	74.31	20.76	0.00	4.37	2.19	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	47.60	62.82	24.64	0.72	1.93	1.93	0.00	0.00	0.72	0.00
putamen, newborn, donor10223	10365-105F5	29.24	27.74	7.50	3.00	0.75	2.25	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	29.38	5.82	4.95	0.58	0.29	0.00	0.00	0.00	0.29	1.16
rectum, fetal, donor1	10067-101I4	119.63	44.51	13.91	2.78	1.39	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	14.20	11.45	5.94	0.21	0.00	0.21	0.00	0.00	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.02	9.94	8.28	2.07	1.66	2.90	0.00	0.00	0.83	1.24
retina, adult, pool1	10030-101E3	27.33	19.88	12.42	0.00	0.10	0.20	0.00	0.00	0.10	0.10
retinoblastoma cell line:Y79	10475-106I7	18.71	37.41	24.68	1.30	0.52	0.52	0.00	0.00	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.43	12.91	8.73	0.74	0.25	0.37	0.00	0.00	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	212.59	129.07	51.18	4.50	3.09	0.84	0.00	0.00	0.00	4.50
sacrococcigeal teratoma cell line:HTST	10695-109G2	122.77	30.31	26.52	1.52	0.76	0.76	0.00	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	13.11	13.92	6.31	0.16	0.49	0.32	0.00	0.00	0.00	0.16
salivary acinar cells, donor2	11772-123I8	20.24	15.97	7.44	0.55	0.83	0.96	0.41	0.00	0.00	0.14
salivary acinar cells, donor3	11773-123I9	23.17	9.27	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	7.44	5.72	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	64.58	11.80	6.41	0.51	0.51	0.17	0.08	0.00	0.17	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	53.84	10.58	8.11	1.06	0.59	0.12	0.12	0.12	0.24	0.35
seminal vesicle, adult	10201-103F3	21.16	18.52	5.82	1.06	2.12	1.59	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	11.42	4.62	3.64	0.00	0.00	0.49	0.00	0.00	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.07	8.56	2.52	0.00	0.25	0.25	0.00	0.00	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	18.06	5.02	3.01	0.00	1.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	21.36	12.63	7.12	0.67	0.40	0.67	0.00	0.00	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	38.91	9.84	4.53	0.44	0.11	0.44	0.00	0.00	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.93	14.45	5.29	0.90	0.00	0.26	0.00	0.00	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	25.54	8.51	7.09	0.00	2.13	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	21.35	9.95	5.28	0.36	0.12	0.12	0.00	0.00	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	70.35	45.23	10.05	1.01	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	13.57	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	106.68	66.28	25.25	3.79	0.00	3.79	0.63	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	75.04	23.68	21.01	1.33	0.33	0.33	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	34.99	30.26	15.45	0.63	0.95	1.26	0.00	0.00	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	6.36	4.63	3.85	0.58	0.77	0.19	0.00	0.00	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	59.01	18.13	16.15	0.49	0.00	0.33	0.00	0.00	0.00	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	13.19	5.31	11.74	0.64	0.64	0.48	0.00	0.00	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	77.58	21.57	20.70	0.87	0.87	0.65	0.00	0.00	0.22	0.65
small intestine, adult, pool1	10024-101D6	68.32	20.78	10.03	1.31	0.24	0.72	0.00	0.00	0.00	0.24
small intestine, fetal, donor1	10064-101I1	45.21	18.18	10.81	0.98	0.49	2.46	0.49	0.25	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	10.77	4.10	2.56	0.00	0.51	0.51	0.00	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	23.00	22.74	12.15	0.26	0.52	0.52	0.00	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	8.58	10.72	5.09	0.00	0.54	0.00	0.00	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	29.59	30.05	16.06	0.46	2.75	1.15	0.00	0.00	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	30.75	33.51	21.29	0.00	0.39	0.39	0.00	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	35.97	31.13	24.21	3.46	3.46	1.38	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	37.81	40.86	21.34	1.22	0.61	1.83	0.00	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	63.37	28.01	14.69	0.92	0.92	1.84	0.00	0.00	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	239.27	34.65	28.08	3.14	0.90	1.34	0.75	3.73	1.05	0.30
spleen, adult, pool1	10025-101D7	46.81	10.46	6.39	0.44	0.22	0.11	0.00	0.00	0.00	0.22
spleen, fetal, pool1	10044-101F8	63.96	12.87	11.84	0.16	0.40	0.08	0.00	0.00	0.16	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	29.09	6.73	6.42	0.52	0.52	0.21	0.00	0.00	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	13.10	4.37	5.32	1.14	0.00	0.19	0.00	0.00	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	44.73	14.33	5.94	0.00	1.40	1.75	0.00	0.00	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.54	5.86	5.08	0.39	0.39	0.00	0.00	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	30.17	15.20	9.68	0.56	0.34	0.45	0.00	0.00	0.34	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	70.32	24.15	14.83	2.12	1.27	1.69	0.00	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	41.88	30.88	13.12	0.85	0.00	0.00	0.00	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	93.98	39.52	21.36	0.00	0.00	0.00	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	11.39	8.55	0.57	0.00	0.57	0.00	0.00	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	24.92	21.81	16.82	1.04	1.25	1.04	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	47.59	35.17	24.83	1.03	1.55	2.59	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	41.69	29.68	2.83	1.41	0.00	0.71	0.00	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	21.09	23.39	12.15	1.60	0.92	1.38	0.00	0.00	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	38.99	28.23	14.58	0.34	0.25	0.08	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	116.81	66.95	41.31	1.42	2.85	2.85	0.71	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	120.87	57.58	24.61	1.76	3.52	1.76	0.00	0.00	1.32	0.44
tenocyte, donor1	11763-123H8	189.56	53.76	30.37	3.49	5.93	6.28	2.79	1.05	1.05	0.70
tenocyte, donor2	11765-123I1	138.49	33.19	16.79	2.29	3.05	2.67	3.82	1.91	0.76	0.76
tenocyte, donor3	11768-123I4	269.84	53.75	31.14	2.97	8.53	10.38	1.48	2.97	3.34	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	60.34	47.76	20.06	1.53	1.36	0.85	0.00	0.00	0.68	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	65.98	26.82	15.72	1.08	0.92	1.70	0.15	0.00	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	47.89	59.36	26.97	1.08	1.70	1.55	0.00	0.00	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	30.85	20.18	8.00	0.63	0.38	0.38	0.13	0.00	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	36.30	29.12	11.35	0.00	0.76	0.38	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	36.43	24.32	11.34	0.44	0.55	0.65	0.33	0.11	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	35.50	15.63	6.19	1.30	4.23	2.61	0.00	0.00	1.30	0.00
testis, adult, pool1	10026-101D8	27.27	13.31	6.87	0.43	0.11	0.00	0.00	0.00	0.11	0.00
testis, adult, pool2	10096-102C6	14.89	8.57	4.06	0.00	0.45	0.00	0.00	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	49.68	35.33	25.39	2.21	1.10	0.00	0.00	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	43.92	33.76	25.01	1.41	1.09	1.41	0.00	0.00	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	117.01	69.28	30.79	1.54	3.08	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.36	22.23	11.03	0.99	1.15	1.48	0.00	0.00	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	25.31	28.77	6.90	1.73	0.58	1.15	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	23.22	14.48	4.99	0.50	1.00	0.50	0.00	0.00	0.00	0.00
throat, fetal, donor1	10061-101H7	63.99	35.65	14.32	0.61	1.52	1.52	0.30	0.00	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	23.05	24.64	10.73	1.39	0.00	0.60	0.00	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	11.53	5.67	3.38	0.00	0.20	0.00	0.00	0.10	0.00	0.00
thymus, fetal, pool1	10043-101F7	20.47	8.52	3.53	0.00	0.10	0.10	0.00	0.00	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	56.64	9.97	8.64	0.80	0.66	0.66	0.00	0.00	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	42.47	8.80	11.73	0.98	0.28	0.84	0.00	0.00	0.28	0.56
thyroid, adult, pool1	10028-101E1	19.69	9.80	4.48	0.28	0.09	0.19	0.00	0.00	0.09	0.09
thyroid, fetal, donor1	10060-101H6	24.78	14.50	5.80	0.26	1.58	0.26	0.00	0.00	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	24.64	9.24	0.00	0.00	0.00	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	17.91	9.54	3.26	0.23	0.23	0.93	0.00	0.00	0.23	0.23
tongue, fetal, donor1	10059-101H5	26.40	23.25	8.28	1.18	0.00	1.58	0.79	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	20.04	6.81	5.31	0.00	0.00	0.10	0.10	0.00	0.00	0.10
trachea, adult, pool1	10029-101E2	30.92	14.31	6.95	0.16	0.08	0.08	0.25	0.00	0.08	0.08
trachea, fetal, donor1	10058-101H4	58.47	49.24	19.23	3.46	1.92	0.77	0.77	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	158.36	22.67	14.17	1.42	2.83	1.42	1.77	2.13	1.77	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	57.65	20.77	15.50	0.41	0.30	0.20	0.00	0.00	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	37.76	10.50	10.03	1.57	0.78	0.47	0.00	0.00	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	138.88	22.83	17.12	0.00	3.81	0.00	0.00	1.90	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	30.14	24.38	8.97	0.17	0.51	0.42	0.00	0.00	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	33.38	18.78	12.52	4.17	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	65.18	34.30	15.53	0.34	0.51	0.51	0.00	0.00	0.17	0.17
uterus, fetal, donor1	10055-101H1	115.70	53.24	32.25	2.56	2.05	0.00	0.00	0.00	0.00	0.51
vagina, adult	10204-103F6	42.00	27.79	12.28	0.00	0.65	0.00	0.00	0.00	0.00	0.65
vein, adult	10191-103E2	27.62	16.22	5.70	0.22	0.66	0.22	0.22	0.00	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	46.73	9.35	12.02	0.53	1.34	0.53	0.00	0.27	0.27	0.53